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Heparan sulfate (HS) and closely related heparin are comprised of 
alternating units of D-glucosamine and either D-glucuronic acid (D-GluA) or L-
iduronic acid (L-IdoA), and support variable degrees of sulfation which can 
interact with a large number of proteins with diverse biological functions. HS 
oligosaccharides can be constructed from readily accessible D-GlcN and D-GlcA 
derivatives, but the inclusion of L-IdoA is less straightforward. To address this, 
our laboratory has developed alternative synthetic strategies for HS-like 
oligosaccharides to incorporate either D-GlcA or L-IdoA in a synthetically efficient 
manner by nucleophilic ring opening of 4-epoxypyranosides, which can be made 
from readily available D-hexoses in few steps. These are derived from 4-
deoxypentenosides (4-DPs), unsaturated pyranosides that can be linked with 
other sugars, enabling us to investigate synthetic strategies involving post-
glycosylative modifications. Terminal 4-DPs have been generated at a late stage 
from  -1,4-linked disaccharides, and also by stereoselective coupling of 4-DP 
thioglycoside donors with various acceptors. The 4’-enol ether can be modified 
by stereoselective epoxidation and ring opening by a dithiocarbamate auxiliary, 
xv 
which can be activated by copper(I) salts for carbon nucleophile addition with 
terminal L-ido configuration. We also explored stereoselective glycosylation of a 
novel glucosamine donor with a N-diphenylphosphinamido group. 
   
1 
CHAPTER I: HEPARIN-LIKE OLIGOSACCHARIDES FOR FGF-2 BINDING 
 
1.1 Introduction to Heparin (HP) and Heparan Sulfate (HS) 
Heparin (HP) and heparan sulfate (HS) are linear, highly sulfated 
polysaccharides with disaccharide repeating units containing (1     4) linked  -D-
glucosamine (GlcN) and uronic acid, either -D-glucuronic acid (-GlcA) or  -L-
iduronic acid ( -L-IdoA).1 Chemically, the distribution of uronic acids in heparin is 
approximately 90% L-IdoA and 10% D-GlcA. HP is a more highly sulfated 
glycosaminoglycan (2.3–2.8 sulfo per disaccharide)2 with molecular weight 
ranging from 5–40 kDa. In HP, the amines may be functionalized with acetyl or 




Figure 1.1 Structure of heparin and heparan sulfate repeat unit 
2 
HS is structurally similar to HP, but with molecular weights ranging from 5–50 
kDa and with a lower percentage of L-IdoA. HS has a lower sulfate density (0.6–
1.5 sulfo/disaccharide) and is heterogeneous in its sulfation patterns.2 HP is often 
referred to as the more completely modified version of HS and also possesses 
the highest negative charge density of any known biological macromolecule.  
However, heparin is found exclusively inside storage vesicles of mast cells of 
some animal species, whereas heparan sulfates are ubiquitous to cell surfaces of 
vertebrates and invertebrate species.3, 4 
The structural microheterogeneity within HP and HS arises during its 
biosynthesis. The sequential biosynthetic processes: a) N-deacetylation and N-
sulfation of GlcN; b) C5 epimerization of D-GlcA into L-IdoA; c) 2-O-sulfonation of 
L-IdoA and D-GlcA, and d) 6-O-sulfonation and 3-O-sulfonation of GlcN  all do not 
go to completion.5 While heparan sulfate contains all of the structural variations 
found in heparin, the frequency of occurrence of the later post-glycosylative 
modifications is higher in HS, and the extent of structural heterogeneity is also 
greater. 
1.2 Heparin-Binding Proteins and Their Biological Importance 
Glycosaminoglycans (GAGs) are a class of complex polysaccharides and 
primary constituents on the surface of every eukaryotic cell and in many 
extracellular matrices. The heterogeneity of HP/HS GAGs arising from their 
variable sulfation pattern and backbone structure enables them to interact with a 
variety of basic proteins such as growth factors, enzymes and morphogens, as 
3 
well as proteins presented by microbial pathogens.6 Among the hundreds of 
proteins known to bind HP/HS in the literature, some representative ones are 
listed in Table 1.1.  
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One well-studied example of a HP–protein interaction involves a specific 
pentasaccharide sequence (Figure 1.2) and the serine protease inhibitor 
antithrombin III (AT-III), which in its activated form inhibits the blood clotting 
cascade.18  Antithrombin-III in its native form is a weak protease inhibitor but 
upon binding with pentasaccharide undergoes a conformational change, resulting 
in a 300-fold increase in the inhibition of the critical serine protease Factor Xa 
4 
(but not of thrombin). This rare sequence contains a highly charged GlcNS,3S,6S 
unit, which is critical for AT III-binding and subsequent anticoagulant properties18. 
A synthetic analog of this pentasaccharide is now marketed as the anticoagulant 
drug Arixtra. 
           
Figure 1.2 Pentasaccharide HP sequence with anticoagulant properties 
 
1.3 Heparin Interaction with Fibroblast Growth Factor -2 
Cell-surface heparan sulfate proteoglycans (HSPGs) in mammalian cells 
frequently act as ligand for extracellular signaling proteins. FGFs are large family 
of monomeric, globular heparin binding growth factors having separate binding 
regions for heparin or HS and fibroblast growth factor receptors (FGFRs). FGF-2 
is one of the most studied proteins that have affinity for HS, and is implicated in 
many physiological and pathological processes, such as embryonic 
development, wound healing, angiogenesis, and tumorigenesis.19  
 





1.3.1 Structure of FGF-2 
FGF-2 (a.k.a. basic FGF) is an 18–34 kDa protein with no signaling sequence 
for secretion. The main portion of FGF-2 consists of 12 anti-parallel  -sheets 
organized into trigonal pyramidal structure.20 There are five isoforms of FGF-2 
(18, 22, 22.5, 24, and 34 kDa) which can be generated by alternate CUG-
translation of start sites and distributed in different subcellular locations.21 The 
smallest of these, FGF-218k, has strong affinity for extracellular HSPGs (Figure 
1.3). The importance of HS for mediating FGF-2 signaling was demonstrated 
when FGF-2 failed to activate HSPG-deficient Chinese hamster ovary (CHO) 
cells transfected with FGFR1, but succeeded when exogenous heparin was 
added.22 HSPGs are known to stabilize the dimerization of FGF-2, especially 
when binding to FGFR dimers at the cell surface (Figure 1.3). Studies suggest 
that this 5-molecule complex activates the mitogen-activated protein kinase 





















































Figure 1.3 (A) 18-kDa FGF-2, a 146-amino acid protein.25 (B) X-ray crystal 
structure of the dimerized FGF-2 dimer/FGFR ectodomain complex, with the HS-
binding groove revealed by sulfate anions.26 (C) Cartoon of 5-molecule complex 
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1.3.2 FGF-2 Synthesis and Storage 
FGF-2 is produced by a wide variety of cell types and is localized within the 
basement membrane (BM), a specialized part of the extracellular matrix 
underneath the endothelial layer, and also on the surfaces of endothelial cells.27  
On the cell surface, FGF-2 binds to high-affinity transmembrane receptors and 
low-affinity HSPGs. Such interactions permit the sequestering of FGF-2s on the 
cell surface and extracellular matrix (ECM), facilitating intracellular transduction 
and stabilization or storage of FGF-2 within the basement membrane.22 This has 
been shown to stimulate cell proliferation and differentiation, implicating the BM 
as a reservoir for FGF-2.  It has been suggested that FGF-2 is released from the 
BM in response to cell damage or non-lethal tissue membrane disruptions.18 The 
storage of FGF-2 within the ECM is diffusion controlled, thanks to its rapid and 
reversible binding with HSPGs.28 Disruption of interactions between FGF-2 and 
HSPG by proteolytic degradation (e.g. heparanases), or by competitive binding 
with soluble heparin can also enhance FGF-2 release.19,20,29 
 
1.3.3   Role of FGF-2 in Disease and Therapy 
FGF-2 proteins are involved in the development and differentiations of various  
range of organs and transport-systems: brain, blood vessel, bone, lung, liver, 
skin, muscle, eye, reproductive system, and hematopoiesis.19 Elevated 
expression of FGF-2 has been demonstrated in a variety of tumor types both in 
vivo and vitro.30 FGF-2 expression can also correlate with the advanced stages 
of tumor growth: For example: FGF-2 is overexpressed by numerous human 
8 
cancer cell lines including those derived from leukemic, and  bladder, gastric, 
overian, and squamous cell carcinoma.31  FGF-2 stored within the extracellular 
matrix can be mobilized by heparanase, which plays a key role in many 
cancers.32 Similarly, the triggered release of stored FGF-2 is also involved in 
wound healing and the repair or replacement of injured tissues.33,34 Given their 
importance in various cellular growth and differentiation processes, therapeutics 
that target FGF-2 activity have been a topic of active investigation.30,34  
 
 
1.3.4    HSPG Binding Sites of FGF-2 
FGF-2 has three high-affinity binding sites that are recognized by HSPGs, 
which function as modulators of FGF-2 activity. One of these (Site 1, Figure 1.4) 
has been extensively characterized because of its direct role between FGF-2 and 
FGFR, which is lined with multiple basic residues.35,36  Two other carbohydrate-
binding domains (Sites 2 and 2') have been identified, and are reported to 
associate with unsulfated heparan derivatives at submicromolar concentrations.37 
Site 2 features polar residues, whereas Site 2' is lined with hydrophobic ones 
(Figure 1.4 A). When compared with the x-ray crystal structure of the FGF FGFR 
complex, it becomes clear that Site 2 is associated directly with FGFR, and thus 
not specific for heparan. However, Site 2' is remote and thus available as a 
binding domain for heparan. This has been validated by an x-ray crystal structure 
of FGF-2 complexed with an unsulfated heparin trisaccharide, L-
IdoA(14)GlcNAc(14)-D-GlcA(14)OMe (Figure 1.4B,C). This 
9 
trisaccharide and its C5" epimer, D-GlcA( 14)GlcNAc(14)-D-
GlcA(14)OMe, were both found to have submicromolar binding with FGF-2. 
 
Figure 1.4 (A) FGF-2/FGFR binding interactions, based on x-ray structural data.26  
(B) X-ray crystal structure of Site 2’ binding to unsulfated trisaccharide.37 (C) 
unsulfated trisaccharide L-IdoA( 14)-D-GlcNAc(14)-D-GlcA(14)OMe.38 
 
 
1.3.5  Interaction of FGF-2 and HS Disaccharides 
Huang and co-workers have synthesized a library of 48 HS-based 
disaccharides, and studied their interactions with FGF-2.39,40 Three highly 
sulfated epitopes were observed to bind FGF-2 with moderate affinity; based on 
this, the authors inferred that the 3’-O-sulfate increased binding affinity, despite 





Table 1.2 Dissociation constants of FGF-2 binding HS-disaccharides40 
Disaccharide structures Sulfonation sites KD FGF-2 ( M) 














1.7 ± 0.3 




17.5 ± 1.8 






9.0 ± 0.2 
 
 
1.4     Synthesis of Heparin-like Oligosaccharides 
Chemical synthesis is a powerful tool for providing access to well-defined 
heparin-like oligosaccharides. However, the synthesis of heparin-like 
oligosaccharides presents several challenges:  a) easy access to L-iduronic acid 
and L-idose; b) differences in the chemical reactivity of L-idoA and D-GlcA as 
building blocks; c) stereoselective formation of the 1,2-cis linkage on GlcN; d) 
optimization of suitable protecting groups for the facile installation of sulfate 
esters at desired positions; and e) reliable methods for backbone homologation.41 
Synthetic strategies of heparin-like oligosaccharides can be either target-oriented 
11 
or diversity-oriented: the latter can support an iterative approach to a variety of 
structures, while the former is often convergent with a focus on step 
economy.42,43 However, with respect to the construction of oligosaccharide 
libraries, the target-oriented approach tends to be tedious and labor-intensive. 
Chemo-enzymatic synthesis44 offers another approach that utilizes specific 
enzymes to carry out key transformations, often cutting out several processing 
steps. However, the chemo-enzymatic approach is limited by enzyme specificity, 
the challenges of purifying polar intermediates, and reaction scale. 
In contrast, diversity-oriented synthesis is based on the design of a unified 
synthetic route based on common intermediates, one that can be diversified 
simply by changing the order of chemical transformations. This approach can be 
used to generate a library of oligosaccharides with the same base structure, for 
screening structure–binding relationships of target receptors. For example, our 
group45 has synthesized a set of monosulfated disaccharide isomers (sulfoforms) 
from a single precursor, using an orthogonal protecting group scheme for five 
different hydroxyls and one amine (Figure 1.5).45 Diversity-oriented synthesis is 
thus an appealing approach for synthesizing all possible epitopes of 
oligosaccharides for evaluating structure–activity relationships. 
 
12 





(1) Capila, I.; Linhardt, R. J. Angew. Chem. Int. Ed. 2002, 41, 390. 
(2) Xu, D.; Esko, J. D. Annu. Rev. Biochem. 2014, 83, 129. 
(3) Nader, H.; Ferreira, T.; Paiva, J. F.; Medeiros, M.; Jeronimo, S.; Paiva, V.; 
Dietrich, C. P. J. Biol. Chem. 1984, 259, 1431. 
(4) Nader, H. B.; Takahashi, H. K.; Straus, A. H.; Dietrich, C. P. Biochim. 
Biophys. Acta 1980, 627, 40. 
(5) Shriver, Z. H.; Capila, I.; Venkataraman, G.; Sasisekharan, R. Handb. 
Exp. Pharmacol. 2012, 159. 
(6) Raman, R.; Sasisekharan, V.; Sasisekharan, R. Chem. Biol. 2005, 12, 
267. 
(7) Jin, L.; Abrahams, J. P.; Skinner, R.; Petitou, M.; Pike, R. N.; Carrell, R. 
W. Proc. Natl. Acad. Sci. U.S.A. 1997, 94, 14683. 
(8) DiGabriele, A. D.; Lax, I.; Chen, D. I.; Svahn, C. M.; Jaye, M.; 
Schlessinger, J.; Hendrickson, W. A. Nature 1998, 393, 812. 
(9) Mach, H.; Volkin, D. B.; Burke, C. J.; Middaugh, C. R.; Linhardt, R. J.; 
Fromm, J. R.; Loganathan, D.; Mattsson, L. Biochemistry 1993, 32, 5480. 
(10) Faham, S.; Hileman, R.; Fromm, J.; Linhardt, R.; Rees, D. Science 1996, 
271, 1116. 
(11) Thompson, L. D.; Pantoliano, M. W.; Springer, B. A. Biochemistry 1994, 
33, 3831. 
(12) Stringer, S. E.; Gallagher, J. T. J. Biol. Chem. 1997, 272, 20508. 
(13) Mikhailov, D.; Young, H. C.; Linhardt, R. J.; Mayo, K. H. J. Biol. Chem. 
1999, 274, 25317. 
(14) Rider, C. C.; Coombe, D. R.; Harrop, H. A.; Hounsell, E. F.; Bauer, C.; 
Feeney, J.; Mulloy, B.; Mahmood, N.; Hay, A.; Parish, C. R. Biochemistry 1994, 
6974. 
(15) Batini , D.; Robey, F. J. Biol. Chem. 1992, 267, 6664. 
(16) Koenig, A.; Norgard-Sumnicht, K.; Linhardt, R.; Varki, A. J. Clin. Invest. 
1998, 101, 877. 
14 
(17) Nelson, R. M.; Cecconi, O.; Roberts, W. G.; Aruffo, A.; Linhardt, R. J.; 
Bevilacqua, M. P. Blood 1993, 82, 3253. 
(18) Laremore, T. N.; Zhang, F.; Dordick, J. S.; Liu, J.; Linhardt, R. J. Curr.
Opin. Chem. Biol. 2009, 13, 633. 
(19) Bikfalvi, A.; Klein, S.; Pintucci, G.; Rifkin, D. B. Endocr. Rev. 1997, 18, 26. 
(20) Nugent, M. A.; Iozzo, R. V. Int. J. Biochem. Cell Biol. 2000, 32, 115. 
(21) Sorensen, V.; Nilsen, T.; Wiedlocha, A. Bioessays 2006, 28, 504. 
(22) Yayon, A.; Klagsbrun, M.; Esko, J. D.; Leder, P.; Ornitz, D. M. Cell 1991, 
64, 841. 
(23) Bernfield, M.; Götte, M.; Park, P. W.; Reizes, O.; Fitzgerald, M. L.; 
Lincecum, J.; Zako, M. Annu. Rev. Biochem. 1999, 68, 729. 
(24) Guimond, S.; Maccarana, M.; Olwin, B.; Lindahl, U.; Rapraeger, A. J. Biol. 
Chem. 1993, 268, 23906. 
(25) Zhang, J.; Cousens, L. S.; Barr, P. J.; Sprang, S. R. Proc. Natl. Acad. Sci. 
U. S. A. 1991, 88, 3446. 
(26) Plotnikov, A. N.; Schlessinger, J.; Hubbard, S. R.; Mohammadi, M. Cell 
1999, 98, 641. 
(27) Reisig, K.; Clyne, A. M. Matrix Biol. 2010, 29, 586. 
(28) Folkman, J.; Klagsbrun, M.; Sasse, J.; Wadzinski, M.; Ingber, D.; 
Vlodavsky, I. Am. J. Pathol. 1988, 130, 393. 
(29) Dowd, C. J.; Cooney, C. L.; Nugent, M. A. J. Biol. Chem. 1999, 274, 5236. 
(30) Goetz, R.; Mohammadi, M. Nature Rev. Mol. Cell Biol. 2013, 14, 166. 
(31) Teicher, B. A.; Ellis, L. M. Antiangiogenic agents in cancer therapy; 
Springer Science & Business Media, 2008. 
(32) Arvatz, G.; Shafat, I.; Levy-Adam, F.; Ilan, N.; Vlodavsky, I. Cancer 
Metast. Rev. 2011, 30, 253. 
(33) van Wijk, X. M.; van Kuppevelt, T. H. Angiogenesis 2014, 17, 443. 
(34) Carter, E. P.; Fearon, A. E.; Grose, R. P. Trends Cell Biol. 2015, 25, 221. 
(35) Pellegrini, L.; Burke, D. F.; von Delft, F.; Mulloy, B.; Blundell, T. L. Nature 
2000, 407, 1029. 
15 
(36) Stauber, D. J.; DiGabriele, A. D.; Hendrickson, W. A. Proc. Natl. Acad. 
Sci. U. S. A. 2000, 97, 49. 
(37) Ornitz, D. M.; Herr, A. B.; Nilsson, M.; Westman, J.; Svahn, C.-M.; 
Waksman, G. Science 1995, 268, 432. 
(38) Westman, J.; Nilsson, M.; Ornitz, D. M.; Svahn, C.-M. J. Carbohydr. 
Chem. 1995, 14, 95. 
(39) Hu, Y.-P.; Zhong, Y.-Q.; Chen, Z.-G.; Chen, C.-Y.; Shi, Z.; Zulueta, M. M. 
L.; Ku, C.-C.; Lee, P.-Y.; Wang, C.-C.; Hung, S.-C. J. Am. Chem. Soc. 2012, 134, 
20722. 
(40) Li, Y.-C.; Ho, I.-H.; Ku, C.-C.; Zhong, Y.-Q.; Hu, Y.-P.; Chen, Z.-G.; Chen, 
C.-Y.; Lin, W.-C.; Zulueta, M. M. L.; Hung, S.-C. ACS Chem. Biol. 2014, 9, 1712. 
(41) Dulaney, S. B.; Huang, X. Adv. Carbohydr. Chem. Biochem. 2012, 67, 95. 
(42) Hu, Y.-P.; Lin, S.-Y.; Huang, C.-Y.; Zulueta, M. M. L.; Liu, J.-Y.; Chang, 
W.; Hung, S.-C. Nature Chem. 2011, 3, 557. 
(43) Hansen, S. U.; Miller, G. J.; Cliff, M. J.; Jayson, G. C.; Gardiner, J. M. 
Chem. Sci. 2015, 6, 6158. 
(44) Xu, Y.; Masuko, S.; Takieddin, M.; Xu, H.; Liu, R.; Jing, J.; Mousa, S. A.; 
Linhardt, R. J.; Liu, J. Science 2011, 334, 498. 






CHAPTER II: SYNTHETIC STUDIES TOWARD L-IDURONSYL 




2.1.1 L-Iduronic acid 
L-Iduronic acid (IdoA) is an important hexuronic monosaccharide component in 
glycosaminoglycans (GAGs) that enhances binding affinity with various proteins 
such as growth factors, enzymes, morphogens, cell-adhesion molecules, and 
cytokines.1 In nature, epimerization of D-glucuronic acid at the C-5 position leads 
to L-iduronic acids (Figure 2.1)1,2 however, this transformation is challenging to 
perform under synthetic conditions. 
Figure 2.1 Epimerization of D-glucuronic acid (D-GlcA)1,2 
 
17 
  Most of the synthetic approaches to heparin-like oligosaccharides incorporate 
L-iduronic acid derivatives using a multistep sequence, and are further 
challenged by poor reactivity as a glycosyl donor.3,4   
 
2.1.2 4-Deoxypentenosides (4-DPs) and Glycals 
 4-Deoxypentenosides (4-DPs) and glycals are cyclic enol ethers derived from 
pyranosides. Glycals are unsaturated at C1 and C2, whereas 4-DPs are 
unsaturated at C4 and C5 (Figure 2.2).  The reactive 1,2-enol ether in glycals can 
undergo various of transformations making them important intermediates in 
carbohydrate synthesis. 4-DPs have been shown to have similar reactivity 
profiles.5 Despite this, they have not been commonly used in oligosaccharide 
synthesis. Our group has reported that 4-DPs can be stereoselectively 
epoxidized using dimethyldioxirane (DMDO) into  - or -epoxypyranosides, 
which are amenable to anti- or syn-selective ring opening to generate novel 
pyranosides with rare or unnatural substituents at the C5 position.6 Inspired by 
these studies, we aimed to further investigate the synthetic utility of 4’-
deoxypentenoside (4’-DPs) as advanced intermediates, for late-stage conversion 




   
 Figure 2.2 Structure of glycal and 4-DPs derived from  -glucopyranoside 
 
 Efficient glycosyl coupling with high stereoselectivity at an advanced stage of a 
multi-step synthesis can be challenging, with few alternative strategies. This 
challenge could be addressed by developing post-glycosylative modifications 
method that allows the stereoselective installation of functional groups at the C5 
position of terminal glycosides with a predetermined anomeric configuration. In 
this chapter we explore the chemistry of 4’-DP-disaccharides as intermediates for 
post-glycosylative modifications en route to L-iduronosyl disaccharides. 
 
2.2 Synthesis of 4’-Deoxypentenosyl Donors and Disaccharides 
 4’-DP-disaccharide can be synthesized in two ways: a) glycosyl couplings with 
4-DP thiophenyl glycosides as donors, and b) the decarboxylative elimination of 
disaccharides with terminal GlcA units.7 
Our work was inspired by some of the previous results from our laboratory. 
Notably, Padungros et al successfully synthesized a 5’-furyl-substituted 
disaccharide with terminal L-ido configuration, starting from peracetylated 












































































Figure 2.3 Synthesis of 5’-furyl-substituted disaccharide with L-ido configuration8 
 
Unfortunately, this approach failed when using an orthogonally protected 
disaccharide intermediate in which the 4’-epoxypentenoside was treated with (2-
furyl)AlEt2 or (2-furyl)ZnBr in THF (Figure 2.4).8 This attempt apparently suffered 
from the low reactivity of 4’-epoxypentenosyl disaccharide, as well as the lability 










 The above hurdles were partially cleared when the 4’-epoxypentenosyl 
disaccharide was subjected to epoxide ring opening by diethyl dithiocarbamate 
(DTC), generated in situ from CS2 and diethylamine in methanol (Figure 2.5). 
Further, the corresponding 5’-DTC could react with furan as a nucleophile when 
activated with CuOTf(C6H6)0.5 at low temperature (–30 to –15 °C). Product 
formation was confirmed by comparison with the 1H NMR spectrum of the same 
compound made previously by Padungros.8 Unfortunately, orthogonally 
protected 5’-DTC disaccharides were again unreactive to CuOTf(C6H6)0.5 
mediated addition of furan. 
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Figure 2.5 Attempted addition of furan to 5’-DTC-substituted pentenoside 
 
2.3 A New Approach to Disaccharides with Terminal L-Ido Configuration 
 To circumvent the issue of poor reactivity, we redesigned the 4’-DP-
disaccharide so that (a) the 3-O-SEM protecting group would be replaced with an 
acetyl (Ac) or benzyl (Bn) group, and (b) a benzyl group would be installed on the 




Figure 2.6 A revised approach toward heparan disaccharides with terminal L-ido 
configuration (R = Bn). 
  
2.4 Synthesis of Glycosyl Donors 
 Orthogonally protected donor 4 was synthesized following the adapted 
protocol (Figure 2.7).8 Commercially available glucose pentaacetate was 
subjected to BF3.Et2O-mediated glycosylation with thiophenol (PhSH) to give 1 in 
90% yield, which was converted into 4,6-p-methoxybenzylidene acetal 2 in 80% 
yield over two steps. Regioselective 3-O-benzylation of 2 gave compound 3 (90% 
yield) followed by 2-O-benzoylation to afford glycosyl donor 4 in 90% yield as a 





Figure 2.7 Synthesis of glycosyl donor 4. Reagents and conditions: 1) BF3.Et2O 
(10 equiv), PhSH (2.0 equiv), CH2Cl2, rt (90%);  2) (i) NaOMe (0.4 equiv), 2:3 
CH2Cl2:MeOH, (ii) PMBDA (3.0 equiv), d-CSA (0.2 equiv), THF, reflux (73% over 
two steps); 3) (i) Bu2SnO (1.6 equiv), toluene, reflux, (ii) BnBr (1.6 equiv), CsF 
(1.6 equiv), DMF, rt (90%); 4) C6H6COCl (2.0 equiv), py, rt (90%). 
 
 
 Orthogonally protected 4-DP monosaccharide donor 6 was synthesized from 4 
by hydrolysis to a 4,6-diol, chemoselective oxidation of the primary alcohol to an 
acid, then decarboxylative elimination under microwave conditions to afford 4-DP 
donor 6 as a white solid (44% yield over three steps, Figure 2.8). 
 
Figure 2.8 Synthesis of 4-DP thioglycoside donor 6. Reagents and conditions: 1) 
4:4:1 AcOH:THF:H2O, 70 °C (92%); 2) (i) BAIB (3.0 equiv), TEMPO (0.4 equiv), 
2:1 CH2Cl2:H2O, rt, (ii) DMFDNpA (5.0 equiv), DMF, 150 °C,  -wave (48% over 
two steps).  
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2.6 Synthesis of Glycosyl Acceptors 
An orthogonally protected glucosamine acceptor 12 was synthesized from D-
glucosamine (Figure 2.9). Intermediate 7 was synthesized in three steps and 
70% yield using an adapted procedure,9 then converted into  -thiotolyl glycoside 
8 in 72% yield as a white solid. Intermediate 8 was deacetylated with catalytic 
sodium methoxide (NaOMe), and protection of the 4,6-diol with p-anisaldehyde 
dimethyl acetal gave 9 in 77% yield over two steps. The phthalimide group of 9 
was converted into an azide to give 10 in 80% yield over two steps. 
 Glucosamine acceptor 12 was obtained from 10 by protecting the C3 
hydroxyl as 2-(trimethylsilyl)ethoxymethyl (SEM) ether 11 in 90% yield, followed 
by regioselective reductive cleavage of the anisylidene ring with dibutylboron 
triflate (Bu2BOTf) and borane–tetrahydrofuran complex (BH3.THF) to afford 4-O-
p-methoxybenzyl (PMB) ether in 90% yield. This was treated with tert-
butyldiphenylsilyl chloride (TBDPS-Cl) to afford 6-O-TBDPS ether in 96% yield. 
Last, oxidative cleavage of the 4-O-PMB ether with 2,3-dichloro-5,6-




Figure 2.9 Synthesis of acceptor 12. Reagents and conditions: 1) (i) NaOMe (1.0 
equiv), MeOH, rt; (ii) Phth2O (1.1 equiv), Et3N (1.1 equiv), MeOH, rt; (iii) Ac2O, 
py, rt (70%, in 3 steps); 2) TolSH (2.0 equiv), BF3.Et2O (10 equiv), CH2Cl2, rt 
(78%); 3) (i) NaOMe (0.4 equiv), 1:1 CH2Cl2:MeOH, 0 °C; (ii) PMBDA (3.0 equiv), 
d-CSA (0.5 equiv), THF, reflux, (77%, 2 steps); 4) (i) NH2C2H4NH2 (20 equiv), n-
BuOH, 100 °C, (ii) Tf2O (5.0 equiv), NaN3 (6.0 equiv), Et3N (2.0 equiv), CuSO4 
(0.5 equiv), py, (92%); 5) SEM-Cl (2.0 equiv), i-Pr2NEt (3.0 equiv), TBAI (0.5 
equiv), CH2Cl2, 40 °C (90%); 6) (i) Bu2BOTf (1.1 equiv), BH3.THF (10 equiv), 0 
°C (90%); (ii) TBDPS-Cl (2.0 equiv), imidazole (3.0 equiv), CH2Cl2, rt (96%); (iii) 




Glucosamine acceptors 14 and 16, with acetyl (Ac) and benzyl (Bn) protecting 
groups at the C3 position respectively, and glycosyl acceptor 18 were also 
prepared (Figure 2.10). Starting from intermediate 10, the C3 hydroxyl was 
acetylated, the 4,6-anisylidene acetal was regioselectively cleaved with Bu2BOTf 
and BH3.THF to yield a C8 alcohol, followed by 6-O-TBDPS protection to afford 
intermediate 13 in 65% yield over three steps. This was converted to an  -benzyl 
glycoside by activating the thiophenyl donor with N-iodosuccinimide (NIS) and 
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silver trifluoromethanesulfonate (AgOTf) in the presence of distilled benzyl 
alcohol (BnOH), followed by deprotection of the PMB group by treatment with 
BF3.Et2O in wet chloroform to afford acceptor 14. 
  Similarly, glycosyl acceptor 16 was synthesized from intermediate 10 in five 
steps via 3-O-benzylation, 4,6-anisylidene acetal reductive cleavage, 6-O-
TBDPS protection, NIS/TfOH-mediated glycosylation, and deprotection of the 4-
O-PMB ether in 59% overall yield. Glycosyl acceptor 18 was synthesized by 
regioselective cleavage of the 4,6-O-benzylidene acetal in glucoside 17 using 


































ii. BH3.THF, TMSOTf, THF 
iii. TBDPS-Cl, im, CH2Cl2



















5) 4Å MS, NaBH3CN
HCl.Et2O, THF, rt
 
Figure 2.10 Synthesis of acceptors 14, 16 and 18. Reagents and conditions: 1) (i) 
Ac2O, py, rt (90%); (ii)  BH3.THF, TMSOTf, –20 °C, THF (82%); (iii) TBDPS-Cl 
(2.0 equiv), imidazole (3.0 equiv), CH2Cl2, rt (96%); 2) (i) 4Å MS, NIS (2.0 equiv), 
AgOTf (0.6 equiv), BnOH (3.0 equiv), 3:1 Et2O:DCE, –20 °C (86% yield, 3:1  : ); 
(ii) BF3.Et2O (4.0 equiv), wet CHCl3, –20 °C, (56%); 3) (i) NaH (5.0 equiv), TBAI 
(0.3 equiv), BnBr (3.0 equiv), imidazole (0.4 equiv), 4:1 THF:DMF, rt (90%); (ii) 
BH3.THF, TMSOTf, –20 °C, THF (85%); (iii) TBDPS-Cl (2.0 equiv), imidazole (3.0 
equiv), CH2Cl2, rt (96%); 4) (i) 4Å MS, NIS (2.0 equiv), TfOH (0.4 equiv), BnOH 
(3.0 equiv), 3:1 Et2O:DCE, –20 °C (92%, 4:1 : ); (ii) BF3.Et2O (4.0 equiv), wet 





2.7 Synthesis of Disaccharides by BSP/Tf2O-Mediated Glycosylation 
 Thioglycosides were activated using 1-benzenesulfinyl piperidine and 
trifluoromethanesulfonic anhydride (BSP/Tf2O) conditions, developed by Crich 
and co-workers,10 as this method has been found to be compatible with a wide 
variety of protecting groups in previous work by our research group.11 
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Mechanistically, BSP/Tf2O activation of thioglycosyl donor involves the 
generation of N-sulfinyl triflate intermediate I at –60 °C. The highly thiophilic 
intermediate activates the thioglycosyl donor to generate disulfonium 
intermediate II, followed by concomitant formation of glycosyl triflate and a 
cationic disulfide byproduct III. Finally, the glycosyl triflate reacts with the 
acceptor (alcohol) in SN2-like fashion to yield  - or -linked disaccharides, 
depending on the configuration of the donor (Figure 2.10). 
 
 
Figure 2.11 Mechanism of  BSP/Tf2O-mediated glycosyl coupling10 
 A variation of the BSP/Tf2O-mediated coupling protocol was developed in our 
lab and used to synthesize heparan disaccharide derivatives (19–22).8 In a 
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typical coupling, a mixture of glycosyl donor, BSP, tri-tert-butylpyrimidine (TTBP), 
and activated 4Å molecular sieves were stirred in dichloromethane at –60 °C for 
30 minutes, then treated with a dilute solution of Tf2O (precooled to –60 °C) for 
30 minutes, followed by dropwise addition of glycosyl acceptor in CH2Cl2 solution 
(again precooled to –60 °C) with additional stirring for one hour. The reaction 
mixture was slowly warmed to –20 °C, then quenched with cold P(OEt)3 and Et3N 
to afford heparan-like disaccharides with high  -stereoselectivity (Table 2.1).
30 













































































































Reagents and conditions: BSP (1.2 equiv), TTBP (2.0 equiv), Tf2O (1.08 equiv), 







2.8 Post-Glycosylative Modification of Disaccharides 
To study the copper triflate-mediated stereoselective addition of furan at the 
C5’ position, 4’-DP disaccharide 25 was synthesized from 21 in three steps by 
hydrolysis of the 4’,6’-acetal, chemoselective TEMPO/BAIB oxidation, and 
decarboxylative elimination following our standard procedure for the synthesis of 
4-deoxypentenosides.12 Anisylidene-protected disaccharide 21 was hydrolyzed in 
a 8:1:1 mixture of CH3COOH:THF:H2O and stirred at 70 °C for 5 hours to obtain 
diol 23 in 86% yield (Figure 2.12).  The same reaction could also be carried out 
using microwave heating at 60 °C for 20 minutes in 70% yield, however we 
preferred thermal conditions for large-scale synthesis.  
The C6’ hydroxyl of 23 was selectively oxidized to carboxylic acid 24 by 
treatment with BAIB and catalytic TEMPO in 1:2 CH2Cl2:H2O mixture at room 
temperature for 45 minutes. This was subjected to decarboxylative elimination in 
DMF using DMFDNpA at 150 °C for 45 minutes under microwave conditions, to 
afford 4’-DP disaccharide 25 in 61% yield over two steps. 
 
2.8.1 Synthesis of 5’-DTC-Activated Derivatives 
4’-DP disaccharide 25 was converted to 4’-O-benzyl-5’-DTC derivative 28 in 
three steps (Figure 2.12). 4’-DP disaccharide 25 was epoxidized with 
dimethyldioxirane (DMDO) in dichloromethane at –70 °C, which proved to be 
highly chemoselective and traceless after workup.13 The reaction mixture was 
allowed to stir at 0 °C for 24 hours to afford 4’-epoxypyranosyl disaccharide 26. 
The 1H NMR peak at 2.81 ppm (C6D6) indicated  -facioselectivity, which was 
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subsequently confirmed by epoxide ring opening with diethyl DTC yielding the 5’-
  adduct 27 in 72% yield over two steps (H5’:   5.85 ppm, d, J = 10.0 Hz).8 It is 
worth noting that some unreacted 4’-DP carried over from the epoxidation step, 
and a slightly more polar byproduct was isolated but not fully characterized. We 
speculate this to be the 5’ adduct, derived from the corresponding 4’-
epoxypentenoside. Lastly, 5’-DTC disaccharide 27 was treated with sodium 
hexamethyldisilazane (NaHMDS) in DMF at –55 °C, followed by benzyl bromide 
































































































Figure 2.12 Synthesis of fully protected C5’-DTC disaccharide 28. Reagents and 
conditions: 1) 4:4:1 AcOH:THF:H2O, 70 °C, 6 h (86%); 2) BAIB (3.0 equiv), 
TEMPO (0.4 equiv), 2:1 CH2Cl2:H2O, rt, 35 min; 3) DMFDNpA (5.0 equiv), DMF, 
150 °C,  -wave, 50 min (61% over two steps); 5) DMDO (3.0 equiv), CH2Cl2, –70 
°C to 0 °C, 24 h; 5) CS2 (1.2 equiv), Et2NH (2.2 equiv), 1:2 THF:MeOH, 0 °C to rt, 
3h (80% over two steps); 6) TBAI (0.4 equiv), BnBr (3.0 equiv), NaHMDS (3.0 




 Two additional DTC-activated carbohydrates (30 and 32) were also prepared 
as model compounds. Tri-O-benzyl glucal 29 was converted to  -glucosyl DTC 
30 in three steps: (i) epoxidation with DMDO in DCM to afford an -epoxide, (ii) 
epoxide ring opening using diethyl-DTC prepared in situ by the reaction of CS2 
34 
and diethylamine in methanol (80% yield over two steps), and (iii) 2-O-
benzylation to yield protected  -DTC glucoside 30 in 85% yield (Figure 2.13).  -
C5’-DTC disaccharide 32 was synthesized from the 4’-DP derivative of 














































Figure 2.13 Synthesis of  -glucosyl DTC 30 and  -C5’-DTC disaccharide 32. 
Reagents and conditions: 1) 0.1 M DMDO in acetone (3.0 equiv), CH2Cl2, –30 to 
–20 °C, 2 h; 2) CS2 (1.2 equiv), Et2NH (2.2 equiv), 1:2 THF:MeOH, 0 °C to rt, 3 h 
(80% over two steps); 3) TBAI (0.4 equiv), BnBr (3.0 equiv), NaHMDS (3.0 
equiv), DMF, –55 °C, 2 h (78%); 4) DMDO in DCM (3.0 equiv), CH2Cl2, –60 to –
30 °C, 48 h; 5) CS2 (1.2 equiv), Et2NH (2.2 equiv), 1:2 THF:MeOH, 0 °C to rt, 2 h 
(61% over two steps); 6) TBAI (0.4 equiv), BnBr (3.0 equiv), NaHMDS (3.0 




2.8.2 C-Furylation of Glycosyl DTCs 
 
 Given our laboratory’s earlier success in using DTC glycosides as donors,14 
we anticipated DTC glycosides to be amenable toward C-furylation, which could 
ultimately be converted to carboxyl group by ozonolysis.5 We thus initiated this 
study using  -DTC glucoside 30 and  -5’-DTC disaccharide 32 as model 
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compounds for C-furylation.  -DTC glucoside 30 was treated with furan in the 
presence of copper triflate, which had been used previously to activate DTCs for 
O-glycosylation.14 C-furyl adduct 33 was formed in 72% isolated yield (entry 5, 
Table 2.2). 
 















1 Cu(OTf)2 furan (neat) 5 h No reaction
2 Cu(OTf)2 furan-DCM(1:1)
Solvent Time





















Note: CuOTf.(C6H6)0.5 was prepared using literature procedure;15 furan was 
freshly distilled over CaH2. In entries 1 and 2, the reaction was warmed to 10 °C. 




 The optimized reaction condition was then applied toward  -5’-DTC 
disaccharide 32 (Figure 2.14). This did not result in a clean addition; however, 
ESI-MS of the crude product yielded a significant signal at m/z 1031, 
corresponding to the [M+Na]+ peak of expected disaccharide 34.
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Figure 2.14 CuOTf-mediated C-furylation of 5’-DTC disaccharide 32. Reagents 
and conditions: CuOTf(C6H6)0.5 (2.1 equiv), furan (32 equiv), 4Å molecular 




  -5’-DTC disaccharide 28 was also subjected to furan addition using the 
optimized conditions for the synthesis of 33. This produced 5’-furyl adduct 35 in 































Figure 2.15 CuOTf-mediated C-furylation of 5’-DTC disaccharide 28. Reagents 
and conditions: CuOTf.(C6H6)0.5 (2.5 equiv), furan (30 equiv), 4Å molecular 





 We have found 4-deoxypentenosyl thioglycosides to be versatile donors using 
the BSP/Tf2O-mediated glycosylation protocol. Post-glycosylational C5  additions 
were investigated using DMDO oxidation and epoxide ring opening by 
nucleophilic DTCs, prepared in situ from diethylamine and CS2, and CuOTf-
mediated furan additions, however C-furylation was not efficient. 
 
38 
2.10 General Methods and Experiments 
 
2.10.1 Experimental 
General methods: All starting materials and reagents were obtained from 
commercial sources and used as received unless otherwise noted. All solvents 
used were freshly distilled prior to use. 1H and 13C NMR spectra were recorded 
on a Bruker ARX400 operating at 400 MHz and 100 MHz or a Bruker AV500HD 
operating at 500 MHz and 125 MHz or Bruker Avance-III-800 operating at 201 
MHz respectively, and referenced to the solvent used (7.16 and 128.06 ppm for 
C6D6, 7.26 and 77.00 ppm for CDCl3) unless stated otherwise. IR spectra were 
acquired from Nicolet- Nexus 670 FTIR by thin film preparation with attenuated 
total reflectance (ATR) technique. Optical rotations were measured at room 
temperature with a Rudolph Research AUTOPOL® III polarimeter. Mass spectra 
were acquired using either a Hewlett-Packard 5989B or a Finnigan 4000 mass 
spectrometer. Column chromatrography was performed with silica gel (Sorbent 
Tech, 32–63 D). Preparative TLC separation was performed with silica gel Prep 
TLC (Sorbent Tech, 500  m). TLC analysis was monitored with silica gel G60F254 
(Sorbent Tech, 250  m) and detected by UV absorption at 256 nm or dipping in 
p-anisaldehyde-sulfuric acid stain solution then charring at 150 °C. 4Å molecular 
sieves were flame-dried using a Bunsen burner under reduced pressure prior to 
use. Tf2O was freshly distilled from P2O5 prior to use. N-iodosuccinimide (38 mg, 
0.168 mmol) was recrystallized from 1:4 acetone:hexanes. BSP was purchased 
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from Sigma–Aldrich and used without further purification. All experiments were 
performed under the argon atmosphere with standard Schlenk line techniques.  
 General method for BSP/Tf2O glycosylation: In a typical procedure, all 
glasswares were flame-dried. Thioglycoside donor (234 mg) and acceptor (396 
mg, 0.58 mmol) were dried separately by azeotropic distillation with toluene (3 x 
5 mL) and dried in high vacuum for 1 h. The glycosyl donor was combined with 
the BSP (101 mg, 0.480 mmol), TTBP (198 mg, 0.80 mmol), and freshly 
activated 4Å molecular sieves (300 mg) under an inert atmosphere and dissolved 
in freshly distilled CH2Cl2 (3 mL), then stirred at rt for 1 h. The solution was 
cooled to –60 °C and stirred for an additional 30 min, after which freshly distilled 
Tf2O (73  L, 0.43 mmol) was added dropwise over 5 minutes. The resulting 
bright orange solution of glycosyl triflate solution was stirred at –60 °C for 15–30 
min and monitored by TLC until the consumption of glycosyl donor was complete, 
then treated with a solution of pre-cooled (–60 °C) acceptor (0.63 mmol) in 
CH2Cl2 (1.5 mL). Stirring was continued at –60 °C for 1 h, and then slowly 
warmed to –20 °C over a period of 4 h. The resulting pale orange solution was 
quenched with P(OEt)3 (138  L, 0.79 mmol) and Et3N (280  L, 2.02 mmol) pre-
cooled to –20 °C, then stirred for an aadditional 15 min. The yellow solution was 
removed from the cooler and slowly warmed to rt over 30 min. The reaction 
mixture was then quenched at 0 °C with saturated NaHCO3 (5 mL), and stirred 
vigorously for 30 min at rt. The suspension was filtered through Celite, extracted 
with CH2Cl2 (3 × 10 mL), washed with brine (3 x 5 mL), dried over Na2SO4, 
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concentrated under reduced pressure, then purified by silica column 
chromatography. 
General method for NIS glycosylation: Thioglycoside (70 mg, 0.092 mmol) 
was dried by azeotropic distillation with toluene (3 x 1 mL) and dissolved in a 1:3 
mixture of DCE:Et2O (1.2 mL) under inert atmosphere, then treated with activated 
4Å molecular sieves (250 mg), freshly distilled benzyl alcohol (25  L, 0.24 mmol), 
and N-iodosuccinimide (38 mg, 0.168 mmol). The reaction mixture was cooled to 
–30 °C for 15 minutes and treated with triflic acid (3.5  L, 0.039 mmol) or AgOTf 
(14 mg, 0.054 mmol), then slowly warmed to –20 °C over one hour. The reaction 
mixture was quenched with Et3N (40  L, 0.29 mmol) at –20 °C, then warmed to 
room temperature and passed through Cellite, washed with saturated sodium 
thiosulfate solution (3 x 2 mL), dried over anhydrous sodium sulfate, 
concentrated to dryness, then purified by silica column chromatography. 
General methods for epoxidation of 4’-DP-disaccharides and epoxide 
ring opening by DTC: In a typical protocol, the glycal 4’-DP (0.03 mmol) was 
dried by azeotropic distillation with toluene (3 × 1 mL) and dissolved in CH2Cl2 
(0.8 mL). This solution was cooled to –70 °C for 15 min, treated with freshly 
prepared 0.1 M DMDO-DCM solution (1 mL, 0.1 mmol) with stirring for 1 h, then 
warmed to –30 °C and stirred for 12–24 h.  The mixture was then concentrated 
(at 0 °C for the best results), azeotroped with toluene (3 x 1 mL), then dissolved 
in dry and degassed THF (0.3 mL) for epoxide ring opening by using freshly 
prepared diethyl dithiocarbamate; prepared in situ in degassed MeOH (4.9 mL) 
from freshly distilled diethylamine (560  L, 5.2 mmol) and freshly distilled CS2 
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(160  L, 2.6 mmol). The ice bath was removed and stirred at rt for 30 minutes to 
obtain a  colorless to slightly pale-yellow solution of diethyl-DTC 
diethylammonium salt (2.6 mmol, 0.53 M in MeOH), which was used 
immediately. The calculated volume of freshly prepared DTC solution was added 
to the epoxide solution in THF at 0 °C under argon atmosphere with stirring for 3 
h. After the completion of reaction, the mixture was concentrated, and purified by 
silica column chromatography to obtain the DTC products. 
General method for 4’-O-benzylation of DTC disaccharides: 4’-O-Benzyl-
5’-DTC disaccharide was prepared by the adapted protocol: 5’-DTC-disaccharide 
(0.1 mmol) was dried by azeotropic distillation with toluene (3 x 1 mL) and 
dissolved in dry DMF (2 mL) at room temperature, then treated with TBAI (8 mg, 
0.02 mmol), cooled to –50 °C for 15 minutes under argon, and treated with 
freshly distilled benzyl bromide (34 L, 0.28 mmol) and 0.6 M NaHMDS solution 
in toluene (500 L, 0.3 mmol). The reaction mixture was stirred for 2–3 hours 
then quenched at –50 °C with saturated ammonium chloride solution (2 mL), 
extracted with diethyl ether (3 x 5 mL), washed with brine (3 x 1 mL), dried over 
anhydrous sodium sulfate, and purified by column chromatography using a 5–
20% ethyl acetate in hexanes gradient. 
General procedure for the CuOTf(C6H6)0.5-mediated furan addition to 
glycosyl dithiocarbamate: Glycosyl DTC donor (0.052 mmol) was dried by 
azeotropic distillation with toluene (3 × 1 mL), dissolved in degassed DCE (0.65 
mL), then introduced into a two-necked flask charged with freshly activated 4Å 
molecular sieves (100 mg) and distilled furan (75  L, 1.04 mmol). The mixture 
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was cooled to –30 °C for 15 minutes and treated with CuOTf.(C6H6)0.5 (27 mg, 
0.104 mmol) which was reserved in a solid addition tube. The reaction mixture 
was slowly warmed to –5 °C over 45–60 minutes, and turned yellow near 
completion. The mixture was quenched with Et3N (35  L, 0.25 mmol) at –5 °C, 
then warmed to room temperature and passed through a pad of Celite and 
diluted with water, extracted with ethyl acetate (3 x 5 mL), washed with brine (3 x 
2 mL), dried over sodium sulfate, then  purified by silica column chromatography. 
Thiophenyl 2-O-benzoyl-3-O-benzyl-4,6-O-p-methoxybenzylidene--
glucopyranoside (4). Glucose pentaacetate was subjected to Lewis-acid 
(BF3.Et2O)-mediated glycosylation with thiophenol (PhSH) to give 1 in 90% yield. 
Glucoside 1 was deacetylated and converted to a 4,6-p-methoxybenzylidene 
acetal 2 in 80% yield over two steps. Regioselective 3-O-benzylation of 2 gave 
compound 3 in 90% yield, and 2-O-benzoylation of compound 3 afforded glycosyl 
donor 4 as a white crystalline solid in 90% yield. 1H and 13C NMR were compared 
and matched with literature:8 1H NMR (300 MHz, CDCl3):  8.02 (d, J = 7.3 Hz, 
2H), 7.61 (t, J = 7.4 Hz, 1H), 7.53–7.37 (m, 6H), 7.36–7.21 (m, 4H), 7.19–7.01 
(m, 4H), 6.92 (d, J = 8.7 Hz, 2 H), 5.57 (s, 1H), 5.29 (dd, J = 8.5, 10.0 Hz, 1H), 
4.85 (d, J = 10.1 Hz, 1H), 4.80 (d, J = 11.9 Hz, 1H), 4.66 (d, J = 11.9 Hz, 1H), 
4.40 (dd, J = 5.0, 10.5 Hz, 1H), 3.96–3.71 (m, 5H), 3.56 (m, 1H), 1.55 (s, 1H). 
Thiophenyl 2-O-benzoyl-3-O-benzyl-4-deoxy--pent-4-enopyranoside (6). 
Thioglycoside 4 (85 mg, 0.14 mmol) was hydrolyzed by 8:1:1 AcOH:THF:H2O  (5 
mL) by heating to 70 °C for 3 h. Upon completion of the reaction, the mixture was 
cooled to room temperature, concentrated and azeotroped with toluene (3 x 5 
43 
mL) to remove residual AcOH, redissolved in ethyl acetate (20 mL), washed with 
brine (3 x 2 mL), dried over Na2SO4, concentrated to dryness, and purified by 
silica gel chromatography using a 20–100% EtOAc in hexanes gradient to afford 
diol 5 (66 mg, 96%) as a white crystalline solid. 
Diol 5 was subjected to TEMPO/BAIB oxidation, quenched with saturated 
sodium thiosulfate solution, extracted with chloroform, dried over sodium 
anhydrous Na2SO4,  and concentrated to afford crude glucuronic acid (65 mg, 
0.13 mmol). This was dried by azeotropic distillation with toluene (3 x 2 mL), 
dissolved in distilled DMF (4 mL) in a sealed microwave tube, and treated with 
DMFDNpA (185  L, 0.66 mmol). The reaction mixture was heated at 150 °C for 
20 minutes under microwave conditions, then concentrated to dryness and 
purified by silica gel chromatography using a 5–10% EtOAc in hexanes gradient 
with 1% Et3N to yield thiophenyl 4-DP glycoside 6 as a white solid (36 mg, 48% 
over two steps). 1H NMR (400 MHz, C6D6):   8.09 (d, J = 8.0 Hz, 2H), 7.53 (d, J = 
7.5 Hz, 2H), 7.25–6.90 (m, 12H), 6.32  (d, J = 6.4 Hz, 1H), 5.90 (d, J = 1.6 Hz, 
1H), 5.76 (d, J = 1.2 Hz, 1H), 4.98 (t, J = 12 Hz, 1H), 4.67 (d, J = 12.4 Hz, 1H), 
4.58 (d, J = 12 Hz, 1H), 3.87 (m, 1H). 13C NMR (100 MHz, C6D6):   164.98, 
142.91, 138.59, 138.58, 136.33, 133.13, , 131.53, 129.93, , 129.00, 128.39, 
128.06, 127.82, 127.75, 127.58, 127.27, 100.87, 83.42, 70.17, 68.29.  IR: 3072, 
2886, 1722, 1649, 1265, 1070, 711, 677 cm-1. []25D = –201° (c= 0.46, CH2Cl2). 
HRESI-MS: m/z calcd. for C25H22O4S [M+Na]+ 441.1136; found 441.1131. 
1,3,4,6-Tetra-O-acetyl-2-deoxy-2-phthalimido--glucopyranoside (7). The 
synthesis of glucosamine 7 was adapted from the literature previously reported 
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from our group.9 Glucosamine hydrochloride (50 g, 232 mmol) was mechanically 
agitated with 1 M NaOMe in MeOH (232 mL) for 2 h at 25 °C, followed by 
addition of finely powdered phthalic anhydride (19 g,128 mmol) and Et3N (35.5 
mL, 255 mmol). The mixture was stirred for 45 min, then treated with a second 
portion of phthalic anhydride (19 g, 128 mmol) and stirred for 24 h at 25 °C. The 
mixture was cooled to –20 °C for 4 h, then concentrated under reduced pressure 
to afford a white solid which was redispersed in pyridine (500 mL) followed by 
slow addition of Ac2O (330 mL) at 0 °C. The reaction mixture was mechanically 
stirred at 25 °C for 48 h, then concentrated to dryness and purified by 
recrystallization in 95% EtOH to afford 7 as an amorphous white solid (77.6 g, 
70% over 3 steps). The product was confirmed by comparison with literature 
NMR data:9 1H NMR (300 MHz, CDCl3):   7.84 (dd, J = 3, 6 Hz, 2H), 7.73 (dd, J
= 3.0, 5.7 Hz, 2H), 6.49 (d, J = 8.7 Hz, 1H), 5.86 (dd, J = 9.3, 10.5 Hz, 1H), 5.19 
(t, J = 9.3 Hz, 1H), 4.44 (dd, J = 8.7, 10.5 Hz, 1H), 4.34 (dd, J = 3.9, 12.3 Hz, 
1H), 4.11 (dd, J = 2.4, 12.3 Hz, 1H), 4.00 (ddd, J = 2.4, 4.8, 10.8 Hz, 1H), 2.08 (s, 
3H), 1.97 (s, 3H), 1.84 (s, 3H); 13C NMR (75 MHz, CDCl3):   170.70, 170.08, 
169.55, 168.71, 167.44, 134.57, 131.26, 123.87, 89.82, 72.67, 70.56, 68.32, 
61.58, 53.55, 20.82, 20.68, 20.48. 
Thiotolyl 3,4,6-tri-O-acetyl-2-deoxy-2-phthalimido--glucopyranoside (8). 
A solution of glucosamine acetate 7 (10 g, 20.9 mmol) and p-thiocresol (3.4 g, 
27.25 mmol) in CH2Cl2 (200 mL) cooled to 0 °C was treated with BF3·Et2O by 
dropwise addition under argon atmosphere, then stirred at room temperature for 
24 h.  The reaction mixture was quenched with saturated NaHCO3 solution (50 
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mL), extracted with CH2Cl2 (3 x 100 mL), washed with brine solution (3 x 25 mL), 
dried over anhydrous Na2SO4, filtered, then concentrated to dryness and the 
crude product was purified by recrystallization in 95% EtOH to afford 
thioglycoside 8 as an amorphous white solid (8.5 g, 75%). 1H NMR (400 MHz, 
CDCl3):  7.87 (dd, J = 3.1, 5.4 Hz, 2H), 7.76 (dd, J = 3.0, 5.6 Hz, 2H), 7.3 (d, J 
=7.1 Hz 2H), (d, J = 7.9 Hz, 2H), 5.77 (t, J = 9.2 Hz, 1H), 5.65 (d, J = 10.6 Hz, 
1H), 5.12 (t, J = 10.2, Hz, 1H), 4.27 (m, 2H), 4.20 (dd, J = 2.4, 12.2 Hz, 1H), 3.88 
(ddd, J = 2.4, 4.9, 10.4 Hz, 1H), 2.33 (s, 3H), 2.10 (s, 3H), 2.02 (s, 3H), 1.83 (s, 
3H); 13C NMR lit.16 (75 MHz, CDCl3):   170.76, 170.22, 169.58, 167.95, 167.08, 
138.89, 134.57, 134.43, 134.04, 131.71, 131.29, 129.77, 127.05, 123.82, 83.22, 
75.95, 71.77, 68.79, 62.31, 53.69, 21.29, 20.90, 20.73, 20.54. 
Thiotolyl 2-deoxy-4,6-O-p-methoxybenzylidene-2-phthalimido--
glucopyranoside (9). A solution of glucosamine triacetate 8 (15.4 g, 28.46 
mmol) in 2:3 CH2Cl2:MeOH (300 mL) was cooled to 10 °C and treated with 1 M 
NaOMe in MeOH (11.5 mL, 11.5 mmol) with stirring at 10 °C for 2 h. When all 
starting material was consumed, the reaction was quenched with activated 
Dowex 50X-W-H+ ion-exchange resin, filtered, dried over sodium sulfate, then 
concentrated to dryness to obtain the crude 3,4,6-triol. This was dried by 
azeotropic distillation with toluene (3 x 15 mL), dissolved in THF (300 mL), 
treated with anisylidene dimethyl acetal (11.78 mL, 69.4 mmol) and d-CSA (1.28 
g, 5.531 mmol), then heated to reflux for 10 h. When all starting material was 
consumed, the reaction was quenched with saturated NaHCO3 solution (50 mL) 
at room temperature, extracted with ethyl acetate (3 x 150 mL), dried over 
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Na2SO4, and concentrated to dryness. The crude product was purified by 
recrystallization in 95% EtOH to obtain 9 as an amorphous white solid (11.7 g, 
77% over 2 steps). 1H NMR (400 MHz, CDCl3):   7.88 (d, J = 4.3 Hz, 1H), 7.83 
(d, J = 2.3 Hz, 1H), 7.77–7.70 (m, 2H), 7.39 (d, J =  9.8 Hz, 2H), 7.27 (d, J = 8.5 
Hz, 2H), 7.06 (d, J = 8.0 Hz, 2H), 6.87 (d, J = 8.7 Hz, 2H), 5.61 (d, J = 10.7 Hz, 
1H), 5.50 (s, 1H), 4.58 (t, J = 9.7 Hz, 1H), 4.36 (dd, J = 4.8, 10.4 Hz, 1H), 4.29 (t, 
J = 10.3 Hz, 1H), 3.80 (m, 4H), 3.64 (td, J = 4.9, 9.6 Hz, 1H), 3.54 (t, J = 9.1 Hz, 
1H), 2.65 (s, 1H), 2.30 (s, 3H). 13C NMR (100 MHz, CDCl3):   160.22, 138.32, 
134.10, 133.21, 131.58, 129.61, 129.32, 127.78, 127.55, 123.74, 123.24, 113.65, 
101.78, 84.37, 81.76, 77.26, 76.94, 76.62, 70.20, 69.66, 68.46, 60.30, 55.54, 
55.22, 21.04, 14.09. 
 Thiotolyl 2-azido-2-deoxy-4,6-O-p-methoxylbenzylidene--gluco-
pyranoside (10). Preparation of TfN3: A suspension of NaN3 (2.8 g, 43.1 mmol) 
in distilled pyridine (25 mL) was treated with distilledTf2O (3.6 mL, 21.3 mmol) at 
0 °C with stirring for 2 h, and used immediately. A solution of phthalimide 9 (3.8 
g, 7.1 mmol) and ethylenediamine (12 mL, 177.8 mmol) in n-butanol (12 mL) in a 
pressure tube was heated at 100 °C with stirring for 10 h. The mixture was 
cooled down to room temperature, concentrated to dryness, azeotroped with 
toluene (3x 15 mL), , then re-dispersed in distilled pyridine (25 mL) and treated  
with with Et3N (2.0 mL, 14.4 mmol), CuSO4·5H2O (890 mg, 3.56 mmol) and 
freshly prepared TfN3 (25 mL) at 0 °C. The mixture was slowly warmed to 25 °C 
and stirred for 3 h. Upon the completion of reaction, the mixture was 
concentrated, azeotroped with toluene (3 x 10 mL), then the crude azide was 
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dispersed into ethyl acetate (30 mL)  and water (5 mL), extracted with ethyl 
acetate (3 x 150 mL), washed with brine (3 x 20 mL), dried over Na2SO4, 
concentrated to dryness and purified by silica column chromatography using a 0–
30% ethyl acetate in hexanes gradient to afford glucosamine 10 as an 
amorphous white solid (3.0 g, 92%). 1H NMR (400 MHz, CDCl3):   7.46 (d, J = 
8.8 Hz, 2H), 7.37 (d, J = 8.7 Hz, 2H), 7.18 (d, J = 7.9 Hz, 2H), 6.88 (d, J = 8.7 Hz, 
2H), 5.48 (s, 1H), 4.48 (d, J = 10.1 Hz, 1H), 4.35 (dd, J = 3.9, 10.7 Hz, 1H), 3.80 
(s, 3H), 3.75 (t, J = 8.8 Hz, 1H), 3.43 (m, 2H), 3.31 (dd, J = 9.0, 10.1 Hz, 1H), 
2.90 (s, 1H), 2.37 (s, 3H). 
Thiotolyl 2-azido-2-deoxy-4,6-O-p-methoxybenzylidene-3-O-[2-
(trimethylsilyl)ethoxymethyl]--glucopyranoside (11). A solution of 
glucosamine 10 (0.48 g, 1.1 mmol), TBAI (206 mg, 0.55 mmol) and DIPEA (0.9 
mL, 5.6 mmol) in dichloromethane (10 mL) was treated with SEM-Cl (0.6  mL, 3.3 
mmol) at room temperature, then refluxed at 40 °C for 12 h. The reaction was 
quenched with saturated sodium bicarbonate solution (5 mL) and stirred at room 
temperature for 4 h, then extracted with dichloromethane (3 x 50 mL), washed 
with brine (3 x 5 mL), dried over anhydrous sodium sulfate, concentrated under 
reduced pressure, and purified by silica gel chromatography using a 0–20% 
EtOAc in hexanes gradient to yield 3-O-SEM ether 11 as colorless syrup (563 
mg, 90%). 1H NMR (400 MHz, CDCl3):   7.46 (d, J = 7.3 Hz,  2H), 7.35 (d, J = 
8.7 Hz, 2H), 7.16 (d, J = 8.7 Hz, 2H), 6.86 (d, J = 9.8 Hz, 2H), 5.46 (s, 1H), 4.94 
(d, J = 6.7 Hz, 1H), 4.80 (d, J = 6.7 Hz, 1H), 4.47 (d, J = 10.1 Hz, 1H), 4.33 (dd, J 
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= 4.9, 10.5 Hz, 1H), 3.8 (s, 3H), 3.7 (m, 3H), 3.49 (m, 3H), 3.28 (t, J = 9.8 Hz, 
1H), 2.37 (s, 3H), 0.88 (t, J = 7.5 Hz, 2H), 0.01 (s, 9H). 
Thiotolyl 2-azido-6-O-(tert-butyldiphenylsilyl)-2-deoxy-3-O-[(2-trimethyl-
silylethoxymethyl)]- -glucopyranoside (12). All glasswares were flame-dried 
before use. Glycoside 11 (1.16 g, 2.1 mmol)  was azeotroped with toluene (3 x 5 
mL), dissolved in a 1 M BH3 solution in THF (20.6 mL, 20.6 mmol), and treated 
with a 1 M Bu2BOTf solution in THF (2.3 mL, 2.3 mmol) at –10 °C, then warmed 
to 0 °C with stirring for 1 h. The reaction was quenched with Et3N (0.58 mL, 2.4 
mmol) followed by the slow addition of cold MeOH (15 mL) at 10 °C until the 
effervescence ceased. The reaction mixture was slowly warmed to room 
temperature, concentrated, azeotroped with methanol (3 x 10 mL), then purified 
by silica gel chromatography using a 0–20% EtOAc in hexanes gradient to afford 
the intermediate C6 alcohol as a syrupy solid (1.02 g, 90%).   
The C6 alcohol was azeotroped with toluene (3 x 5 mL), dissolved in distilled 
dichloromethane (18 mL) at room temperature, treated with imidazole (367 mg, 
3.06 mmol) and TBDPS-Cl (530 L, 2.04 mmol), and stirred for 4 h at room 
temperature under argon. The reaction was quenched with saturated ammonium 
chloride solution (20 mL), extracted with dichloromethane (3 x 100 mL), dried 
over sodium sulfate, concentrated, then purified by silica column chromatography 
using a 0–20% ethyl acetate in hexanes gradient to obtain the intermediate 6-O-
TBDPS ether as colorless syrup (1.45 g, 96% yield).   
A portion of the orthogonally protected intermediate (1 g, 1.25 mmol) was 
dissolved in 1:10 H2O:CH2Cl2 (27.5 mL) and treated with DDQ (480 mg, 2.11 
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mmol) at room temperature for 1 h. The reaction was quenched with saturated 
sodium thiosulfate solution (25 mL), washed with sodium bicarbonate solution 
(30 mL), extracted with dichloromethane, dried over sodium sulfate, concentrated 
to dryness, then purified by silica gel chromatography using a 0–5% acetone in 
hexanes gradient  to afford C4 alcohol 12 as a colorless syrup (660 mg, 78% 
yield). The product was confirmed by comparison with literature NMR data.8 1H 
NMR (400 MHz, CDCl3):   7.76 (dt, J = 7.9, 1.6 Hz, 4H), 7.52 (d, J = 8.0 Hz, 2H), 
7.40 (m, 6H), 7.05 (d, J = 8.0 Hz, 2H), 4.93 (d, J = 7.2 Hz, 1H), 4.76 (t, J = 7.5 
Hz, 1H), 4.48 (d, J = 1.2 Hz, 1H), 4.37 (d, J = 11.4 Hz, 1H), 4.03 (dd, J = 2.2, 
11.1 Hz, 1H), 3.94 (dd, J = 4.5, 11.1 Hz, 1H), 3.82 (m, 1H), 3.6 (m, 1H), 3.32 (m, 
2H), 2.32 (s, 3H), 1.07 (s, 9H), 0.97 (m, 2H), 0.01 (s, 9H). 
Thiotolyl 3-O-acetyl-2-azido-2-deoxy-4-O-p-methoxybenzyl-6-O-(tert-
butyldiphenylsilyl)--glucopyranoside (13). Intermediate 10 (1.4 g, 3.26 mmol) 
was acetylated to yield the 3-O-acetate (1.38 g, 90%). A portion of this (1.14 g, 
2.42 mmol) was azeotroped with toluene (3 x 5 mL) and treated with 1 M BH3 
solution in THF (12.1 mL) and TMSOTf (90 L, 0.5 mmol) at –30 °C, then slowly 
warmed to 0 °C and stirred at this temperature for 6 h. The reaction was 
quenched with triethylamine (3.3 mL, 23.86 mmol) followed by slow addition of 
methanol (10 mL), then warmed to room temperature and concentrated with 
azeotropic distillation using additional methanol (3 x 10 mL), then purified by 
silica gel column chromatography using a 10–40% ethyl acetate in hexanes 
gradient to afford the C6 alcohol as a white solid (938 mg, 82%).  
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A portion of this C6 alcohol (680 mg, 1.43 mmol) was dissolved in 
dichloromethane (11 mL), treated with TBDPS-Cl (740  L, 2.88 mmol) and 
imidazole (290 mg, 4.26 mmol) at 0 °C, then warmed to room temperature and 
stirred for an additional 2 h. The reaction was quenched with saturated 
ammonium chloride solution (10 mL), extracted with dichloromethane (3 x 50 
mL), washed with brine (3 x 5 mL), dried over sodium sulfate, and purified by 
silica column chromatography using a 0–10% ethyl acetate in hexanes gradient 
to afford 6-O-TBDPS ether 13 as a white solid (920 mg, 90% yield). 1H NMR (400 
MHz, CDCl3):   7.99 (m, 2H), 7.89 (m, 2H), 7.71 (d, J = 7.9 Hz, 2H), 7.34 (m, 
5H), 7.20 (m, 3H), 6.92 (d, J = 7.9 Hz, 2H), 6.81 (d, J = 8.3 Hz, 2H), 5.41 (t, J = 
9.6 Hz, 1H), 4.62 (t, J = 6.6 Hz, 1H), 4.22 (d, J = 10.2 Hz, 1H), 3.94 (m, 2H), 3.76 
(t, J = 9.5 Hz, 1H), 3.36 (s, 3H), 3.31 (t, J = 9.8 Hz, 1H), 2.99 (d, J = 9.7 Hz, 1H), 
2.04 (s, 3H), 1.73 (s, 3H), 1.27 (s, 9H); 13C NMR (100 MHz, CDCl3):   169.70, 
159.26, 138.55, 135.77, 135.53, 135.11, 134.71, 133.98, 133.21, 132.68, 129.73, 
129.55, 129.32, 127.74, 127.64, 127.24, 113.78, 85.96, 79.90, 77.26, 77.14, 
76.94, 76.62, 76.22, 74.92, 74.28, 63.03, 62.17, 55.20, 26.84, 26.47, 21.11, 
20.84, 19.25, 18.93. 
Benzyl 2-azido-3-O-acetyl-6-O-(tert-butyldiphenylsilyl)-2-deoxy--
glucopyranoside (14). A flame-dried two-necked round-bottom flask was 
charged with activated 4Å molecular sieves (650 mg) and equipped with a solid 
addition tube containing AgOTf (73 mg, 0.28 mmol). A solution of thioglycoside 
13 (312 mg, 0.44 mmol), distilled benzyl alcohol (175 L, 1.69 mmol), and 
recrystallized NIS (217 mg, 0.96 mmol) in 1:3 DCE:ether (5 mL) was added, 
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cooled to –30 °C for 15 minutes, then treated with AgOTf from the solid addition 
tube. The reaction mixture was warmed to –20 °C with stirring for 2 h, then 
quenched with triethylamine (200  L, 1.44 mmol) and warmed to room 
temperature. The mixture was passed through Celite, then washed with sodium 
thiosulfate solution (3 x 5 mL) and brine (3 x 5 mL), dried over sodium sulfate, 
then concentrated and purified by column chromatography using 0–10% ethyl 
acetate in hexanes gradient to yield  -benzyl glycoside as the major product 
(63%, colorless syrup) and -benzyl glycoside as the minor product (20%).  
A portion of  -benzyl glycoside (160 mg, 0.23 mmol) was dissolved in wet 
chloroform (4 mL) and treated with BF3.Et2O (145 L, 1.15 mmol) at –25 °C with 
stirring for 30 minutes. The reaction was quenched with saturated sodium 
bicarbonate solution (5 mL) at –20 °C, warmed to room temperature, extracted 
with dichloromethane (3 x 50 mL), washed with brine (3 x 5 mL), dried over 
sodium sulfate, filtered and concentrated, then purified by silica column 
chromatography using a 10–30% ethyl acetate in hexanes gradient to give 
glucosamine acceptor 14 as a colorless syrup (315 mg, 56%). Note: acetyl 
transfer between C3 and C4 of product was observed. 1H NMR (400 MHz, 
CDCl3):  7.71 (ddd, J =1.9, 3.7, 8.0 Hz, 4H), 7.34 (m, 11H), 5.39 (dd, J = 8.6, 
10.6 Hz, 1H), 5.00 (d, J = 3.6 Hz, 1H), 4.65 (m, 2H), 3.90 (d, J = 3.8 Hz, 2H), 
3.75 (m, 2H), 3.25 (dd, J = 3.5, 10.6 Hz, 1H), 2.77 (s, 1H), 2.19 (s, 3H), 1.09 (s, 
9H). 
Thiotolyl -2-azido-3-O-benzyl-6-O-(tert-butyldiphenylsilyl)-2-deoxy-4-O-p-
methoxybenzyl--glucopyranoside (15). C3 alcohol 10 (1 g, 2.33 mmol) was 
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dissolved in 1:4 DMF:THF (12 mL) along with imidazole (63 mg, 0.93 mmol), and 
TBAI (344 mg, 0.93 mmol) and cooled to 0 °C for 30 minutes. The reaction 
mixture was treated with 60% sodium hydride (450 mg, 18.75 mmol) in small 
portions and stirred for 1 h, then treated with benzyl bromide (830  L, 6.98 
mmol), warmed to room temperature, and stirred for an additional 4 h. The 
reaction was quenched with saturated ammonium chloride (10 mL) and stirred for 
1 h, then extracted with ethyl acetate (3 x 100 mL), washed with brine (3 x 5 mL), 
dried over sodium sulfate, and concentrated to dryness. The crude product was 
purified by silica gel chromatography using a 0–20% ethyl acetate in hexanes 
gradient to yield the 3-O-benzyl ether as a white solid (1.08 g, 90%).  
A portion of this product (273 mg, 0.52 mmol) was treated with BH3.THF (2.6 
mL, 2.6 mmol) and TMSOTf (20  L, 0.21 mmol) at –20 °C, followed by additional 
workup and purification steps as described for compound 13 to yield a C6 alcohol 
as a colorless syrup (232 mg, 85%). A portion this intermediate (180 mg, 0.34 
mmol) was dissolved in in dichloromethane (3.5 mL) and treated with TBDPS-Cl 
(177  L, 0.68 mmol) and imidazole (70 mg, 1.03 mmol)  at room temperature for 
1 h, followed by additional workup and purification steps as previously described 
to afford 6-O-TBDPS ether 15 as a colorless syrup (236 mg, 90%). 1H NMR (400 
MHz, CDCl3):  7.87 (dd, J = 1.4, 7.6 Hz,  2H), 7.79 (dd, J = 1.7, 8.2 Hz, 2H), 
7.60 (d, J = 8.1 Hz, 2H), 7.43 (m, 9H), 7.09 (t, J = 9.6 Hz, 2H), 6.85 (d, J = 8.6 
Hz, 2H), 4.92 (s, 2H), 4.84 (d, J = 10.3 Hz, 1H), 4.67 (d, J = 10.3 Hz, 1H), 4.42 
(d, J = 10.1 Hz, 1H), 4.02 (m, 2H), 3.82 (m, 4H), 3.57 (t, J = 9.3 Hz, 1H), 3.39 (m, 
2H), 2.36 (s, 3H), 1.16 (s, 9H). 
53 
Benzyl 2-azido-3-O-benzyl-6-O-(tert-butyldiphenylsilyl)-2-deoxy- -
glucopyranoside (16). Glucosamine intermediate 15 (447 mg, 0.58 mmol) was 
azeotroped with toluene (3 x 5 mL), then dissolved in 1:3 DCE:ether (4.5 mL) and 
treated with NIS (265 mg, 1.17 mmol), distilled benzyl alcohol (125 L, 1.2 
mmol), and 4Å activated molecular sieves (800 mg) under argon atmosphere. 
The reaction mixture was cooled to –30 °C for 15 minutes, then treated with triflic 
acid (22 L, 0.25 mmol) and warmed to –10 °C for 1.5 h, followed by standard 
aqueous workup as previously described (cf. 14). The crude product was purified 
by silica gel chromatography using a 0–10% ethyl acetate in hexanes gradient to 
afford the -benzyl glycoside as the major product and -benzyl glycoside as the 
minor product (410 mg, : 3:1 ratio, 93% combined yield).  
The -benzyl glycoside (1.33 g, 1.79 mmol) was subjected to deprotection of 
4-O-PMB as previously described (cf. 14). The crude product was purified by 
silica gel chromatography using a 10–30% ethyl acetate in hexanes gradient to 
afford C4 alcohol 16 as a colorless syrup (970 mg, 87%). 1H NMR (400 MHz, 
CDCl3):  7.53 (m, 20H), 4.94 (d, J = 3.6 Hz, 1H), 4.91 (d, J = 10.8 Hz, 1H), 4.83 
(d, J = 11.1 Hz, 1H), 4.70 (d, J = 12.1 Hz, 1H), 4.54 (d, J = 12.1 Hz, 1H), 3.89 (m, 
2H), 3.85 (d, J = 3.2 Hz, 2H), 3.72 (d, J = 5.7 Hz, 2H), 3.30 (m, 1H), 2.47 (s, 1H), 
1.07 (s, 9H). 
Methyl 2,3,6-tri-O-benzyl- -glucopyranoside (18). 4,6-O-benzylidene acetal 
17 (200 mg, 0.433 mmol) was dried by azeotropic distillation with toluene (3 x 5 
mL) in a two-necked round-bottomed flask, then dissolved in dry THF (6 mL) and 
treated with sodium cyanoborohydride (285 mg, 4.33 mmol) under inert 
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atmosphere. The flask was equipped with an addition funnel charged with 1 M 
solution of HCl in ether (5.5 mL, 5.5 mmol). The reaction mixture was cooled to 0 
°C for 15 min, treated with dropwise addition of HCl-ether while stirring, then 
warmed to room temperature with stirring for another 3 h. The reaction was 
diluted with water (5 mL) and ethyl acetate (50 mL), then treated with solid 
sodium bicarbonate until a neutral pH was achieved. The mixture was extracted 
with ethyl acetate, washed with brine (3 x 5 mL), dried over sodium sulfate, then 
concentrated and purified by silica gel chromatography using a 10–40% ethyl 
acetate in hexanes gradient to afford C4 alcohol 18 as a colorless syrup (154 mg, 
77%). 1H NMR (400 MHz, CDCl3):   7.55 (m, 15H), 5.05 (d, J = 11.7 Hz, 1H), 
4.80 (d, J = 11.7 Hz, 1H), 4.71 (d, J = 3.5 Hz, 1H), 4.4 (m, 4H), 4.09 (t, J = 9.1 
Hz, 1H), 3.97 (m, 1H), 3.76 (m, 3H), 3.57 (dd, J =3.5, 9.5 Hz, 1H), 3.20 (s, 3H), 
2.39 (s, 1H). 
Thiotolyl 2-azido-4-O-(3’-O-benzyl-2’-O-benzoyl-4’,6’-O-p-methoxy-
benzylidene--glucopyranosyl)-6-O-tert-butyldiphenylsilyl-3-O-(2-trimethyl-
silylethoxymethyl)--glucopyranoside (19). Glycosyl donor 4 (234 mg, 0.40 
mmol) and glucosamine acceptor 12 (396 mg, 0.58 mmol) were dried separately 
by azeotropic distillation with toluene (3 x 2 mL). Donor 4 was treated with BSP 
(101 mg, 0.48 mmol), TTBP (198 mg, 0.8 mmol) and 4Å activated molecular 
sieves (500 mg) in distilled CH2Cl2 (4 mL), then cooled to –60 °C for 15 minutes 
and treated dropwise with freshly distilled and pre-cooled Tf2O (73 L, 0.43 
mmol), with stirring at –60 °C for another 30 minutes. To this mixture, a pre-
cooled (–60 °C) solution of glucosamine acceptor 12 in CH2Cl2 (3 mL) was added 
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via cannula, stirred for 1 hour at  –60 °C, then slowly warmed to –25 °C over a 
period of 3 h. The resulting pale orange solution was quenched with pre-cooled 
P(OEt)3 (138  L, 0.79 mmol) and Et3N (280  L, 2.02 mmol) at –25 °C, then 
stirred for another 15 min. This yellow solution was removed from the bath and 
warmed to rt over 30 min. The suspension was then filtered through Celite, 
diluted with water, extracted with CH2Cl2 (3 × 10 mL), washed with brine (3 x 5 
mL), dried over Na2SO4, then concentrated and purified by silica gel 
chromatography using a 5–30% EtOAc in hexanes gradient with 1% Et3N to 
afford the desired disaccharide 19 as a white foamy solid (340 mg, 73%). 1H 
NMR (400 MHz, CDCl3):   7.78 (dd, J = 7.2, 11.8, Hz, 4H), 7.63 (m, 2H), 7.43 (m, 
9H), 7.31 (m, 2H), 7.20 (m, 2H), 7.09 (m, 4H), 6.95 (m, 4H), 5.56 (s, 1H), 5.21 (t, 
J = 9.2, Hz, 1H), 5.0 (d, J = 6.9 Hz, 1H), 4.93 (d, J = 8.1 Hz, 1H), 4.87 (d, J = 6.9 
Hz, 1H), 4.82 (d, J = 12.2 Hz, 1H), 4.68 (d, J = 12.3 Hz, 1H), 4.40 (dd, J = 5.0, 
10.6 Hz, 1H), 4.24 (d, J = 10.1 Hz, 1H), 4.10 (t, J = 9.4 Hz, 1H), 3.84 (s, 3H), 
3.76  (m, 4H), 3.65 (m, 3H), 3.55 (t, J = 9.3 Hz, 1H), 3.37 (dt, J = 5.0, 9.7 Hz, 
1H), 3.21 (t, J = 9.8 Hz, 1H), 2.96 (d, J = 9.7 Hz, 1H), 2.28 (s, 3H), 1.09 (s, 9H), 
0.99 (m, 2H), 0.06 (s, 9H); 13C NMR (101 MHz, CDCl3):   164.49, 160.04, 
138.62, 137.86, 135.76, 135.36, 134.34, 133.41, 133.02, 131.96, 130.10, 129.82, 
129.68, 129.58, 129.01, 128.26, 128.12, 127.94, 127.73, 127.42, 127.24, 126.56, 
113.59, 101.16, 100.10, 96.60, 85.78, 81.77, 79.72, 78.96, 77.90, 77.25, 77.14, 
76.93, 76.61, 74.67, 73.71, 73.43, 68.54, 66.04, 63.74, 60.69, 55.24, 26.75, 




-glucopyranoside (20). Glycosyl donor 4 (50 mg, 0.08 mmol) was subjected to 
the BSP glycosylation as described above (cf. 19) using BSP (21 mg, 0.10 
mmol), TTBP (42 mg, 0.17 mmol), Tf2O (16 L, 0.09 mmol), and 4Å mol sieves 
(140 mg) in CH2Cl2 (0.6 mL). A solution of pre-cooled (–60 °C) acceptor 14 (68 
mg, 0.12 mmol) in CH2Cl2 (0.4 mL) was added to the reaction mixture with 
stirring at –60 °C for 1 h, then slowly warmed to –40 °C over 1 h. The reaction 
was quenched with pre-cooled P(OEt)3 (27 L, 0.15 mmol) and Et3N (55 L, 0.39 
mmol) at –40 °C, warmed to room temperature, followed by workup as previously 
described. The crude product was purified by silica gel chromatography using a 
5–30% EtOAc in hexanes gradient with 1% Et3N to afford disaccharide 20 as an 
amorphous solid (30 mg, 34%). 1H NMR (400 MHz, CDCl3):  7.23 (m, 29H), 
5.57 (s, 1H), 5.46 (t, J = 10.0 Hz, 1H), 5.25 (t, J = 8.5 Hz, 1H), 4.92 (d, J = 3.6 
Hz, 1H), 4.87 (d, J = 8.0 Hz, 1H), 4.81 (d, J = 12.3 Hz, 1H), 4.68 (d, J = 12.1 Hz, 
1H), 4.54 (d, J = 12.4 Hz, 1H), 4.40 (m, 2H), 4.12 (m, 2H), 3.69 (m, 6H), 3.51 (d, 
J = 11.5 Hz, 4H), 3.17 (dd, J = 3.6, 10.7 Hz, 1H), 2.12 (s, 3H), 1.06 (s, 9H). 
Benzyl 2-azido-4-O-(3’-O-benzyl-2’-O-benzoyl-4’,6’-O-p-
methoxybenzylidene- -glucopyranosyl)-3-O-benzyl-6-O-tert-butyldiphenyl-
silyl-2-deoxy--glucopyranoside (21). Glycosyl donor 4 (100 mg, 0.17 mmol) 
and acceptor 16 (92 mg, 0.15 mmol) were subjected to BSP glycosyl coupling 
conditions as previously described (cf. 19), using BSP (43 mg, 0.20 mmol), TTBP 
(80 mg, 0.32 mmol), 4Å mol sieves (280 mg) in CH2Cl2 (1.2 mL), and Tf2O (31 
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 L, 0.18 mmol). Acceptor 16 was dissolved in CH2Cl2 (0.6 mL) prior to addition. 
The reaction mixture was stirred at –60 °C for 2 h, then quenched and worked up 
as previously described. The crude product was purified by silica gel 
chromatography using a 5–30% EtOAc in hexanes gradient with 1% Et3N to 
afford the desired disaccharide 21 as a colorless syrup (124 mg, 66%). 1H NMR 
(400 MHz, CDCl3):    7.73 (ddd, J =1.3, 6.9, 8.1 Hz, 4H), 7.69 (m, J = 2H), 7.54 
(dt, J = 1.3, 7.4 Hz, 1H), 7.44 (m, 10H), 7.32 (m, 6H), 7.14 (m, 8H), 6.94 (m, 2H), 
5.54 (s, 1H), 5.34 (m, 1H), 5.09 (d, J = 10.2 Hz, 1H), 4.99 (dd, J = 1.3, 8.1 Hz, 
1H), 4.89 (d, J = 3.7 Hz, 1H), 4.84 (d, J = 12.2 Hz, 1H), 4.76 (d, J = 10.3 Hz, 1H), 
4.70 (d, J = 12.2 Hz, 1H), 4.47 (d, J = 2.4 Hz, 2H), 4.25 (m, 2H), 3.94 (dd, J = 
9.0, 10.4 Hz, 1H), 3.84 (d, J = 1.0 Hz, 4H), 3.73 (m, 2H), 3.57 (t, J = 10.4 Hz, 
1H), 3.46 (d, J = 11.8 Hz, 1H), 3.36 (m, 2H), 3.27 (d, J = 9.8 Hz, 1H), 1.03 (s,  J = 
1.2 Hz, 9H); 13C NMR (101 MHz, CDCl3):   164.91, 160.24, 138.49, 138.05, 
136.82, 136.05, 135.54, 133.86, 133.23, 132.55, 130.20, 129.90, 129.47, 128.61, 
128.52, 128.41, 128.35, 128.27, 128.06, 127.96, 127.89, 127.76, 127.67, 127.48, 
113.79, 101.36, 100.54, 96.71, 82.07, 78.28, 78.16, 75.95, 75.77, 74.03, 73.88, 
71.49, 69.88, 68.67, 66.33, 63.12, 60.88, 55.46, 26.88, 19.54. 
Methyl 2,3,6-tri-O-benzyl-4-O-(2-O-benzoyl-3-O-benzyl-4-deoxy--pent-
4-enopyranosyl)--glucopyranoside (22). Thiophenyl 4-DP donor 6 (55 mg, 
0.13 mmol) was treated with BSP (33 mg, 0.16 mmol), TTBP (65 mg, 0.26 
mmol), and 4Å molecular sieves (300 mg) in CH2Cl2 (1.0 mL), followed by the 
dropwise addition of Tf2O (24 L, 0.14 mmol) at –60 °C with stirring for 30 min. A 
solution of acceptor 18 (80 mg, 0.17 mmol) in CH2Cl2 (0.5 mL) pre-cooled to –60 
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°C was added, with stirring at –60 °C for another 2 h. The reaction was quenched 
and worked up as previously described (cf. 19), and the crude product was 
purified by silica gel chromatography using a 5–50% EtOAc in hexanes gradient 
with 1% Et3N to yield 4 -DP disaccharide 22 as a white solid (53 mg, 52%). 1H 
NMR (400 MHz, C6D6):   8.06 (d, J = 7.2 Hz, 2H), 7.49 (d, J = 7.5 Hz, 2H), 7.36–
6.96 (m, 21 H), 6.20 (d, J = 6.4 Hz, 1H), 5.84 (t, J = 3.5 Hz, 1H), 5.69 (d, J = 3.8 
Hz, 1H), 5.20 (d, J = 11.5 Hz, 1H), 5.02 (d, J = 11.5 Hz, 1H), 4.81 (t, J = 5.6 Hz, 
1H), 4.59 (d, J = 3.6  Hz, 1H), 4.55 (m, 4H),  4.33–4.27 (m, 2H), 4.22 (t, J = 9.2 
Hz, 1H), 4.00 (t, J = 3.6 Hz, 1H), 3.92 (dd, J = 3.5, 11.0 Hz, 1H), 3.83 (m, 1H), 
3.59 (dd, J = 1.8, 10.9 Hz, 1H), 3.51 (dd, J = 3.6, 9.4 Hz, 1H), 3.04 (s, 3H). 13C 
NMR (100 MHz, C6D6):   165.08, 142.80, 140.16, 127.89, 127.65, 127.41, 
127.41, 100.17, 98.12, 96.96, 96.95, 80.62, 79.91, 79.91, 77.47, 77.47, 75.02, 
73.18, 73.18, 72.82, 70.35, 70.35, 70.17, 69.73, 69.73, 68.65, 54.52, 54.52.  IR: 
3030, 2924, 1724, 1651, 1601, 1453, 1265, 1107, 1028, 912, 799, 698 cm-1. 
[]25D = +65.14° (c 3.5, CH2Cl2). HRESI-MS: m/z calcd for C47H48NaO10 [M+Na]+ 
795.3140, found 795.3168. 
Benzyl 2-azido-4-O-(2’-O-benzoyl-3’-O-benzyl--glucopyranosyl)-3-O-
benzyl-6-O-tert-butyldiphenylsilyl-2-deoxy--glucopyranoside (23). A 
solution of disaccharide 21 (0.45 g, 0.41 mmol) in 4:4:1 AcOH:THF:H2O (9 mL) 
was heated to 70 °C and stirred for 5 h, then cooled to rt. and concentrated to 
dryness. The crude product was dissolved in ethyl acetate (30 mL), washed with 
brine (3 x 2 mL), dried over sodium sulfate, then concentrated and purified by 
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silica gel chromatography using a 20–50% ethyl acetate in hexanes gradient to 
afford 23 as a white crystalline solid (766 mg, 86%). 1H NMR (400 MHz, CDCl3):  
  7.82–7.76 (m, 4H), 7.69 (d, J = 9.2 Hz, 2H), 7.56–7.14 (m, 24H)  5.27 (t, J = 
11.0 Hz, 1H), 5.07 (d, J = 10.6 Hz, 1H), 4.91 (m, 2H), 4.81 (d, J = 10.7 Hz, 1H), 
4.66 (m, 2H), 4.47 (m, 2H), 4.18 (t, J = 9.5 Hz, 1H), 3.94 (t, J = 9.6 Hz, 1H), 3.72 
(m, 3H), 3.52 (m, 3H), 3.37 (dd, J = 3.7 ,10.3 Hz, 1H), 3.27 (m, 2H), 2.36 (s, 1H), 
1.08 (s, 9H). 
Benzyl 2-azido-4-O-(2’-O-benzoyl-3’-O-benzyl-4-deoxy--pent-4’-
enopyranoside)- 3-O-benzyl-6-O-tert-butyldiphenylsilyl--D-glucopyranoside 
(25). A solution of diol 23 (151 mg, 0.15 mmol) in 2:1 CH2Cl2:H2O (3 mL) was 
treated with BAIB (150 mg, 0.46 mmol) and TEMPO (11 mg, 0.07 mmol) with 
stirring at room temperature for 50 min. The reaction mixture was quenched with 
Na2S2O3 (5 mL) at 0 °C  with vigorous stirring for 30 minutes, extracted with 
EtOAc (3 × 20 mL), washed with brine (3 x 5 mL), dried over Na2SO4, then 
concentrated to dryness to afford crude glucuronic acid 24 (158 mg, 0.16 mmol). 
This was azeotroped with toluene (3 x 2 mL), redissolved in degassed DMF (3 
mL), treated with DMFDNpA (220 L, 0.79 mmol), then heated at 150 °C for 50 
minutes in a microwave reactor. The reaction mixture was then concentrated to 
dryness, azeotroped with toluene  (3 x 5 mL), redissolved in ethyl acetate and 
was washed with brine (3 x 2 mL), dried over Na2SO4, then concentrated and 
purified by silica gel chromatography using a 5–20% EtOAc in hexanes gradient 
with 0.5% Et3N to afford the desired disaccharide 25 as white solid (90 mg, 61%). 
1H NMR (400 MHz, C6D6):   8.05 (d, J = 8.5 Hz,  2H), 7.91–7.88 (m, 3H), 7.85–
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7.80 (m, 3H), 7.58 (d, J = 8.2 Hz,  2H), 7.35–6.95 (m, 20H), 6.24 (d, J = 6.4 Hz, 
1H), 5.92 (t, J = 4.0 Hz, 1H), 5.89 (d, J = 4.4 Hz, 1H), 5.35 (d, J = 11.4 Hz, 1H), 
4.86–4.80 (m, 2H), 4.56–4.53 (m, 3H), 4.49 (t, J = 9.5 Hz, 1H), 4.27 (m, 1H), 4.23 
(d, J = 4.5 Hz, 1H), 4.12–4.07 (m, 2H), 4.0 (dd, J = 2.3, 12.0 Hz, 1H), 3.72 (dd, J 
= 1.6 ,11.9 Hz, 1H), 3.56 (d, J = 11.0 Hz, 1H), 3.17 (dd, J = 3.6, 10.3 Hz, 1H), 
1.17 (s, 9H). 
Benzyl 2-azido-4-O-(2’-O-benzoyl-3’-O-benzyl-5’-diethyldithiocarbamoyl-
 -glucopyranoside)-3-O-benzyl-6-O-tert-butyldiphenylsilyl-2-deoxy--
glucopyranoside (27). Disaccharide 25 (27 mg, 0.3 mmol) was dried by 
azeotropic distillation with toluene (3 x 1 mL), dissolved in distilled 
dichloromethane (0.3 mL) then cooled to –70 °C and treated with a freshly 
prepared solution of 0.1 M DMDO in DCM (0.9 mL, 0.1 mmol). The reaction 
mixture was slowly warmed to –30 °C over 4 h and stirred for an additional 20 h 
at –30 °C before warming to rt. The reaction was concentrated to dryness and 
azeotroped with toluene (3 x 1 mL) to afford epoxide 26, which was used without 
further purification. 1H NMR (400 MHz, C6D6):  8.02 (d, J = 7.8 Hz, 2H), 7.90 (m, 
2H), 7.50 (d, J = 7.5 Hz, 2H), 7.30 (d, J = 6.9 Hz, 4H), 7.21 (m, 10H), 7.03 (m, 
10H), 5.63 (m, 2H), 5.23 (d, J = 11.5 Hz, 1H), 4.77 (m, 3H), 4.48 (m, 4H), 4.19 (d, 
J = 12.3 Hz, 1H), 4.08 (m, 2H), 3.92 (dd, J = 10.3, 15.1 Hz, 1H), 3.65 (d, J = 11.7 
Hz, 1H), 3.46 (t, J = 11.8 Hz, 1H), 3.15 (dd, J = 4.2, 10.2 Hz, 1H), 2.81 (d, J = 2.5 
Hz, 1H), 1.20 (s, 9H).  
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The crude epoxide 26 (26 mg, 0.03 mmol) was dissolved in degassed THF 
(0.35 mL) under argon atmosphere, cooled to 0 °C for 15 minutes, then treated 
with freshly prepared diethylammionium diethyldithiocarbamate as a 0.53 M 
solution in methanol (170  L, 0.09 mmol) with stirring for 3 h. The reaction 
mixture was concentrated to dryness and purified by silica gel chromatography to 
afford disaccharide 27 as colorless syrup (24 mg, 80% over two steps). 1H NMR 
(400 MHz, CDCl3):  7.82 (m, 2H), 7.77 (d, J = 7.2 Hz, 2H), 7.70 (m, 2H), 7.54  
1H),  5.30 (t, J = 8.3 Hz, 1H) 5.10 (d, J = 10.3 Hz, 1H), 5.00 (d, J = 8.1 Hz, 1H), 
4.87 (m, 2H), 4.76 (d, J = 13.4 Hz, 1H), 4.67 (d, J = 10.3 Hz, 1H), 4.45 (d, J = 5.7 
Hz, 2H), 4.22 (t, J = 9.4 Hz, 1H), 4.14 (m, 1H), 4.00 (dt, J = 9.9, 4.8 Hz, 1H), 3.93 
(dd, J = 8.8, 10.4 Hz, 1H), 3.63 (t, J = 9.1 Hz, 1H), 3.51–3.44 (m, 2H), 3.35 (d, J 
= 4.5 Hz, 1H), 3.33 (d, J = 3.7 Hz, 1H), 3.28 (d, J = 10.0 Hz, 1H), 1.23 (dd, J = 
7.8, 14.3  Hz,  6H), 1.09 (s, 9H). 
Benzyl 2-azido-4-O-(2’-O-benzoyl-3’,4’-O-dibenzyl-5-diethyldithiocarbam-
oyl--D-glucopyranosyl)-3-O-benzyl-6-O-tert-butyldiphenylsilyl-2-deoxy--
glucopyranoside (28). Disaccharide 27 (50 mg, 0.045 mmol) was subjected to 
low-temperature benzylation following the procedure described below (cf. 32) to 
afford 4’-O-benzyl disaccharide 28 as a syrup (47 mg, 88%). 1H NMR (400 MHz, 
C6D6):  8.07 (d, J = 7.4 Hz, 2H), 8.01 (d, J = 7.7 Hz, 2H), 7.97 (d, J = 7.2 Hz, 
2H), 7.64 (d, J = 7.5 Hz, 2H), 7.40–7.18 (m, 16H), 7.14–6.90 (m, 11H), 6.46 (d, J 
= 10.1 Hz, 1H), 5.92 (t, J = 8.7 Hz, 1H), 5.49 (d, J = 8.1 Hz, 1H), 5.42 (d, J = 11.0 
Hz, 1H), 4.83–4.64 (m, 5H), 4.59 (t, J = 9.4 Hz, 1H), 4.46 (d, J = 3.6 Hz, 1H), 
4.25 (d, J = 11.5 Hz, 1H), 4.18–3.99 (m, 4H), 3.84 (t, J = 9.2 Hz, 1H), 3.74 (d, J = 
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11.1 Hz, 2H), 3.52 (d, J = 10.0 Hz, 1H), 3.46 (m, 1H), 3.17 (m, 1H), 3.12 (dd, J = 
3.6, 10.4 Hz, 1H), 2.87 (m, 1H), 1.39 (s, 9H), 0.93 (t, J = 7.1 Hz, 3H), 0.69 (t, J = 
7.1 Hz, 3H). 
N,N-Diethyldithiocarbamoyl 2,3,4,6-tetra-O-benzyl- -glucopyranoside 
(30). Glycal 29 (140 mg, 0.34 mmol) was dried by azeotropic distillation with 
toluene (3 x 2 mL), dissolved in dichloromethane (0.5 mL), then treated with 
freshly prepared DMDO as a 0.1 M solution in acetone (5.6 mL, 0.5 mmol) with 
stirring at –30 °C for 2 h. The reaction was concentrated to dryness, azeotroped 
with toluene (3 x 1 mL), then treated with freshly prepared diethylammionium 
diethyldithiocarbamate as a 0.53 M solution in methanol (550 L, 0.29 mmol). 
This was stirred at rt for 3 h to afford the corresponding -DTC-glycoside (156 
mg, 80% in two steps), which was used without further purification.  
A portion of the -DTC glycoside (140 mg, 0.24 mmol) was subjected to 
benzylation as previously described (cf. General Procedures) to afford 2-O-
benzyl ether 30 as a white solid (126 mg, 78%). 1H NMR (400 MHz, C6D6):   
7.55–7.04 (m, 20H), 6.39 (d, J = 8.7 Hz, 1H), 4.92 (m, 6H), 4.78 (d, J = 11.4 Hz, 
1H), 4.52 (d, J = 11.9 Hz, 1H), 4.34 (d, J = 11.9 Hz, 1H), 4.10 (ddd, J = 2.4, 6.4, 
9.2 Hz, 1H), 3.84 (m, 6H), 3.17 (m, 2H), 1.05 (t, J =  8.4 Hz, 3H), 0.82 (t, J = 7.1 
Hz, 3H). 
Benzyl 2,3,6-tri-O-benzyl-4-O-(2,3,4’-tri-O-benzyl-5-
diethyldithiocarbamoyl- -pyranosyl)- -glucopyranoside (32). 4’-DP 
disaccharide 31 (22 mg, 0.026 mmol) was treated with DMDO as a 0.1 M 
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solution in DCM (780  L, 0.078 mmol) at 0 °C and stirred for 12 h. The reaction 
mixture was concentrated to dryness to obtain crude epoxide (25 mg, 0.029 
mmol), which was treated with diethylammionium diethyldithiocarbamate as a 
0.53 M solution in methanol (245  L, 0.13 mmol). The reaction mixture was 
stirred at 0 °C and warmed to rt for 1.5 h, then concentrated to dryness and 
purified by preparative TLC using 20% ethyl acetate in hexanes to afford the 5’-
DTC disaccharide as colorless syrup (16 mg, 61% over two steps). This was 
treated with NaHMDS (80  L, 0.048 mmol), TBAI (2 mg, 0.0054 mmol) and 
benzyl bromide (6  L, 0.05 mmol) in dry DMF (0.3 mL) at –55 °C for 1 h, followed 
by aqueous workup and purification (cf. 30) to afford 4’-O-benzyl disaccharide 32 
as a syrup (15 mg, 88%). 1H NMR (400 MHz, C6D6):  7.72–7.68 (m, 2H), 7.57–
7.53 (m, 2H), 7.38–7.05 (m, 31H), 6.22 (d, J = 10.3 Hz, 1H), 5.29–5.03 (m, 2H), 
5.00–4.50 (m, 14H), 4.48–3.97 (m, 3H), 3.98–3.41 (m, 8H), 3.23–2.77 (m, 2H), 
0.92 (t, J = 6.5 Hz, 3H), 0.71 (t, J =  8.3 Hz, 3H). 
C-Furyl 2,3,4,6-tetra-O-benzyl--glucopyranoside (33). DTC glycoside 30 
(24 mg, 0.036 mmol) was dried by azeotropic distillation with toluene (3 x 1 mL), 
treated with freshly distilled furan (70  L, 0.97 mmol) and 4Å activated molecular 
sieves (50 mg) in distilled dichloroethane (0.4 mL), then cooled to –30 °C for 15 
minutes. This mixture was treated with CuOTf(C6H6)0.5 (0.072 mmol) and warmed 
to –10 °C in 45 minutes. The reaction was quenched with Et3N (25  L, 0.18 
mmol) at –10 °C, warmed to rt, then passed through Celite and washed with 
dichloromethane (20 mL). The organic portion was washed with brine (3 x 1 mL), 
dried over sodium sulfate, concentrated to dryness, then purified by preparative 
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TLC using 15% ethyl acetate in hexanes with 1% triethylamine to afford 
compound 33 (15 mg, 72% yields).1H NMR (400 MHz, C6D6):    7.44 (d, J = 1.8 
Hz, 1H), 7.29–7.10 (m, 17H), 7.12 (dd, J = 2.6, 7.0 Hz, 2H), 6.44 (d, J = 3.3 Hz, 
1H), 6.26 (dd, J =1.8, 3.3, Hz, 1H), 5.03 (d, J = 6.5 Hz, 1H), 4.91 (d, J = 10.8 Hz, 
1H), 4.74 (dd, J = 6.9, 10.8 Hz, 2H), 4.55 (d, J = 6.4 Hz, 2H), 4.50 (d, J = 12.1 
Hz, 1H), 4.41–4.34 (m 2H), 4.13 (t, J = 9.2 Hz, 1H), 3.86 (dd, J = 6.4, 9.7 Hz, 
1H), 3.66–3.56 (m, 2H), 3.53–3.41 (m, 3H). 
Benzyl 2,3,6-tri-O-benzyl-4-O-(2’,3’,4’-Tri-O-benzyl-5’--furyl--pyranosyl)-
-glucopyranoside (34). 5’-DTC disaccharide 32 (14 mg, 0.013 mmol) was 
treated with freshly distilled furan (30 L, 0.97 mmol) and 4Å activated molecular 
sieves (40 mg) in distilled dichloroethane (0.3 mL), cooled to –30 °C, then treated 
with freshly prepared CuOTf(C6H6)0.5 (0.027 mmol) as previously described (cf. 
33). The reaction was warmed to –5 °C in 1 h, then quenched with Et3N (10 L, 
0.072 mmol) and worked up as previously described to afford a mixture 
containing 5’-furyl adduct 34, which was identified by ESI-MS: m/z calcd. for 
C64H64O11Na [M + Na]+, 1031.4346; found, 1031.5700. 
Benzyl 2-azido-4-O-(2’-O-benzoyl-3’,4’-O-dibenzyl-5’--furyl--
glucopyranosyl)-3-O-benzyl-6-O-tert-butyldiphenylsilyl-2-deoxy--gluco-
pyranoside (35). 5’-DTC disaccharide 28 (10 mg, 0.008 mmol) was dried by 
azeotropic distillation with toluene (3 x 1mL), treated with freshly distilled furan 
(15 L, 0.21 mmol) and 4Å activated molecular sieves (20 mg) in distilled 
ClCH2CH2Cl (0.18 mL) and cooled to –30 °C for 15 minutes, then treated with 
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freshly prepared CuOTf(C6H6)0.5 (0.02 mmol), and warmed to –20 °C over 1 h. 
The reaction was quenched with Et3N (6  L, 0.043 mmol) at –20 °C, and worked 
up as previously described (cf. 33) to afford compound 35 (3 mg, 32%). Selected 
1H NMR peaks (400 MHz, C6D6):   8.16 (m, 4H), 7.90 (m, 10H), 7.26 (m, 11H), 
7.03 (m, 10H), 6.39 (d, J = 3.3 Hz, 1H), 5.99 (m, 2H), 5.73 (dq, J = 8.3, 3.9 Hz, 
2H), 5.52 (d, J = 3.6 Hz, 1H), 5.11 (d, J = 11.2 Hz, 1H), 4.72 (m, 12H), 4.12 (m, 
20H), 3.05 (m, 1H), 1.16 (m, 1H), 1.16 (s, 9H). (+)-ESI-MS: m/z calcd. for 
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CHAPTER III: SYNTHETIC STUDIES ON THE STEREOSELECTIVE 
GLYCOSYLATION OF GLUCOSAMINE DONORS 
 
3.1 Stereoselective Glycosidic Bond Formations with D-Glucosamine 
Numerous biomolecules like heparin, heparan sulfate, their derivatives and 
natural products such as antibiotics1 (e.g. tunicamycins and neomycin) and 
bacterial antioxidants2 (e.g. mycothiol and bacillithiol) contain D-GlcN units as  
core components.  -Glucosaminyl bonds can be effectively achieved using 
neighboring group participation of acyl groups at C2; however, stereoselective 
formation of  -glucosaminyl bonds remains a challenge in carbohydrate 
synthesis.3 The presence of non-participating groups masking the C2 amine 
(e.g., 2,3-trans-oxazolidinone, p-methoxybenzylidene, or azide) is commonly 
employed in the synthesis of 1,2-cis glycosides, but these groups cannot ensure 
a highly stereoselective outcome.4,5 While the  -product is often favored by the 
stereoelectronic anomeric effect, the stereoselectivity of glycosylation can be 
poor, requiring other modes of stereocontrol such as SN2-like reactivity or 
directing groups, both of which can be engineered by judicious design of 
protecting groups on the donor or acceptor.6 
To address  -stereoselectivity in D-glucosaminyl glycosylation, Kerns and co-
workers initially reported a strategy using 2,3-trans-oxazolidinone glycosyl donors 
to introduce conformational strain in the activated intermediate; but its application 
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was limited by the high loading of promoter (PhSOTf) as well as side reactions 
such as N-glycosylation and -sulfenylation.7,8 Furthermore,  -stereoselectivity 
was highly dependent on the choice of acceptor.9 Later modifications such as N-
acetylation10-12 or benzylation13,14 combined with proper tuning of activators and 
solvents gave higher stereoselectivity and yields. 
Stereoselective synthesis of 1,2-cis-amino glycopeptides via conjugate 
addition of serine/threonine to 2-nitrogalactals was reported by Schmidt and co-
workers.15 Gin and co-workers reported the ring opening of aziridine-2-
carboximide with lactol nucleophiles to form  -O-serine glycosides with good 
stereoselectivity.16 These methods were of limited substrate scope. Hung and co-
workers reported an optimized set of orthogonal protecting groups for a D-
glucosaminyl donor (with azide group at C2) that afforded glucosamine-linked 
oligosaccharides with high  -stereoselectivity, using a 1,6-anhydro--L-
idopyranoside as an acceptor and TMSOTf as a promotor.5 However, this 
strategy was limited to the axial C4 hydroxyl of L-iduronate acceptors. 
A novel method of stereoselective synthesis of 1,2-glucosaminosides via 
nickel-catalyzed glycosylation with N-benzylidene glucosamine and 
galactosamine trichloroacetimidates was reported by Nguyen and co-
workers.17,18 They found a nickel (II) catalyst that can coordinate with the 
approaching acceptor and the C2 benzylideneamino group on the donor, 
resulting in stereoselective  -glycosylation.19,20 The ligand on the nickel catalyst 
and the substituents on the C2 benzylideneamino moiety were highly influential 
in controlling the stereoselectivity of glycosylation. Electron-withdrawing 
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substituents helped to decrease reaction time, which translated into increased  -
selectivity of glycosyl couplings, and was applied toward the synthesis of several 
challenging targets.4,21  
In Chapter I (Section 1.3.4), we described an intriguing findings by Ornitz et 
al. that FGF-2 possesses a secondary binding site for unsulfated heparan 
trisaccharides with submicromolar binding affinity.22 Our group has focused on 
the synthesis of a heparan trisaccharide ligand (Figure 3.1). Initial synthetic 
attempts were based on known glycosyl coupling methods,23 but were hampered 
by: (a) low  -stereoselectivity in the coupling of our glucosaminyl donor (unit B) 








Figure 3.1 Heparan trisaccharide ligand with high affinity for secondary binding 
site on FGF-2. 
 
To address the first bottleneck, we envisioned applying the  -stereoselective 
Ni-catalyzed glycosylation methodology by designing an appropriate N-
benzylidene glucosaminyl trichloroacetimidate.20 This can be prepared in a few 



































 Figure 3.2 Retrosynthetic analysis of target trisaccharide 
 
3.2 Synthesis of Trichloroacetimidate Donor 42 
Glucosamine derivative 36 was subjected to reductive cleavage of 4,6-O-
anisylidene acetal using BH3.THF and TMSOTf, followed by 6-O-benzylation to 
afford 37 in 70% yield over two steps (Figure 3.3). Compound 37 was then 
subjected to azide reduction followed by condensation with p-
flurorobenzaldehyde to produce N-benzylideneamine 38 in 66% yield over two 
steps. Normally, oxidation of the anomeric thiotolyl group should produce lactol 
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formation with mercuric chloride, NIS/AgOTf, or NIS/NBS oxidation proved 
fruitless. On the other hand, the thiotolyl group of 37 was readily oxidized by N-
bromosuccinimide in acetone, which upon hydrolysis and acetylation afforded 
compound 40 in 80% yield over two steps. Aza-ylide formation under Staudinger 
conditions followed by addition to 4-fluorobenzaldehyde afforded imine 41 in 87% 
yield. Hydrolysis of the anomeric acetate with an ammonia–methanol solution, 
followed by treatment with DBU and trichloroacetonitrile, produced 










Figure 3.3 Synthesis of trichloroacetimidate donor 42. Reagents and conditions: 
(1) (i) BH3.THF (5.0 equiv), TMSOTf (0.2 equiv), CH2Cl2, –30 to –5 °C, 5 h; (ii) 
NaH (3.0 equiv), TBAI (0.2 equiv), BnBr (2.0 equiv), imid. (0.5 equiv), 1:4 
DMF:THF, 4 h (81%); (2) (i) Bu3P (1.2 equiv), CH2Cl2, 0 °C, 1 h; (ii) p- 
(CF3)C6H4CHO (1.5 equiv), 0 °C, 2 h (70%); (3) NBS (2.0 equiv), acetone, –30 
°C to –20 °C, 1.5 h, (ii) Ac2O (3.0 equiv), Py, rt (80%); (4) (i) Bu3P (1.2 equiv), 
CH2Cl2, 0 °C, 1 h; (ii) p-FC6H4CHO (1.5 equiv), 0 °C, 2 h (87%); (5) (i) NH3, 
MeOH, THF; (ii) DBU (0.5 equiv), CCl3CN (3.0 equiv), CH2Cl2, 0 °C, 6 h (54%). 
 
   
3.3 Synthesis of Disaccharide by Coupling of Trichloroacetimidate Donor 42 
The trichloroacetimidate donor was subjected to Ni(4-FC6H4(CN))4(OTf)2 
catalyzed coupling with acceptor 43, synthesized previously in our lab. A product 



























Figure 3.4 Glycosyl coupling of donor 42 with acceptor 43. Reagents and 
conditions:  Acceptor 43 (1.2 equiv), Ni[4-F-PhCN]4(OTf)2 (10 mol%), CH2Cl2, rt. 
 
 
With this result, we assessed the pitfalls of the synthetic route: (a) inability to 
remove thiotolyl group in the presence of the C2 benzylideneamine, (b) 
challenges to efficiently convert the C2 azide lactol into a benzylideneamine; (c) 
conversion of the lactol into a trichloroacetimidate donor, which proceeded in 
only fair yield. 
To address these limitations, we considered to replace the TCA group with a 
thioimidate (-S-C(=N)-) moiety: 2-mercaptobenzoxazole (-SBox), 2-mercapto-
benzothiazole (-SBaz), 2-mercaptopyridine (-SPy), and 2-mercatopyrimidine. To 
make these donors, we synthesized azidoglucose derivative 46 (Figure 3.5) in 
84% yield by a diazo transfer reaction with commercially available glucosamine 





Figure 3.5 Synthesis of diazo transfer reagent 45 and azidoglucose 46. Reagents 
and conditions: (1) (i) SO2Cl2 (1.0 equiv), MeCN, (ii) imidazole (2.0 equiv), (iii) 
25% HCl in EtOH (excess); (2) (i) imidazole-1-sulfonyl azide hydrochloride (1.2 
equiv), CuSO4 (0.2 equiv), K2CO3 (2.4 equiv), MeOH, rt, 10 h; (3) Ac2O (8.0 
equiv), py, rt, 4h (84% over two steps). 
 
  
Glucosamine intermediate 46 was subjected to various Lewis-acid mediated 
glycosylation conditions to generate thioimidate donors. Among these, only S-
Box glycoside 47 could be produced in decent yields as an anomeric mixture 
(entry 3, Table 3.1). This was subjected to deacetylation using a saturated 
solution of NH3 in MeOH or DBU in MeOH followed by 4,6-O-anisylidene 
formation. However, saponification proceeded in poor yields with hydrolysis of 
the –SBox group as a major side reaction.  
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Table 3.1 Preparation of glycosyl thioimidates 
[a] Product could not be differentiated from starting material by TLC, but detected 
by ESI-MS. [b] Bu3Sn–SBaz was freshly prepared by adapting a literature 
procedure.25 
 





3.4 Synthesis of C2-N-diphenylphosphinic Amide 
Trichloroacetimidate Donor 50 
 
The preparation of alkyl aryl sulfides from 2-sulfanylbenzothiazole using 
phenyl diphenylphosphinite and azide was reported by Mukaiyama and co-
workers by oxidation–reduction condensation, in which chiral secondary and 
tertiary alcohols were converted into the corresponding chiral sulfides with 
inversion of configuration.26,27 We hypothesized that lactol 48 could form cyclic 
intermediate 48a, from which phenoxide acts as a leaving group when treated 





































































 We tested our hypothesis toward thioglycosides by treating lactol 48 with 
commercially available phenyl diphenylphosphinite (Ph2POPh) in toluene. The 
conspicuous absence of phenoxy (PhO) signals was noted in the 
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characterization of lactol 48a by 1H and 13C NMR; (+)ESI-MS also confirmed the 
absence of intermediate 48a. Instead, diphenylphosphinic amide 49 was 
obtained and confirmed by 1H, 13C NMR, (+)ESI-MS, and acetylation (48c). 
Therefore, trichloroacetimidate donor 50 was synthesized from azidoglucose 46 
in three steps (Figure 3.7): saponification with saturated NH3 solution in methanol 
to afford 48 in 78% yield; heating with phenyl diphenylphosphinite at 60 °C to 
afford N-diphenylphosphinamide 49 in 68% yield; treatment with 










Figure 3.7 Synthesis of trichloroacetimidate glucosamine donor 50. Reagents 
and conditions: (1) 7 M NH3-MeOH (excess), –40 to –10 °C, 1:1 DCM:MeOH, 2 h 
(78%); (2) Ph2POPh (1.2 equiv), degassed toluene, 60 °C, 2 h (68%); (3) CCl3CN 

















































3.5 Coupling Reactions of Trichloroacetimidate Donor 50 by Ni(II) Catalyst 
 
We sought to utilize the method developed by Nguyen and co-workers, in 
which trichloroacetimidate donors are coupled with various glycosyl acceptors 
under [Ni(4-FPhCN)4(OTf)2]-catalyzed conditions with high  -stereo-
selectivity.19,20 We thus explored the coupling of donor 50 with various acceptors 
under similar conditions (Table 3.2). 
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[a] Catalyst was prepared in situ at 0 °C, then warmed to rt for 40 min.  
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3.6 Conclusion and Future Directions 
 In this study, we have investigated [Ni(4-F-PhCN)4(OTf)2]-mediated 
glycosylation of trichloroacetimidate donor 50, which produced  -glycosides with 
selected acceptors. Trichloroacetimidate donor 50 is a novel glycosyl donor 
which can potentially have a broader scope, if issues of reactivity with sterically 
encumbered acceptors can be addressed. More studies are needed with variable 
substituents on phenyl groups of the phosphinamide moiety. 
 
3.7 General Methods and Experiments 
 
3.7.1 Experimental 
 General methods of preparation of imidazole-1-sulfonyl azide 
hydrochloride 45. The procedure was adapted from the literature.24 In a typical 
experiment, NaN3 (4.8 g, 73.85 mmol) was dispersed into dry acetonitrile (70 mL) 
and cooled to 0 °C for 15 minutes. SO2Cl2 was added dropwise and stirred for an 
additional 30 minutes at 0 °C, then brought to room temperature and stirred for 
another 20 h. To the milky white mixture was added recrystallized imidazole (10 
g, 147 mmol) at 0 °C in small portions. This was stirred at 0 °C for 30 minutes 
and then at room temperature for 3 h.  The white precipitate thus obtained was 
diluted with ethyl acetate (200 mL) and washed with saturated sodium 
bicarbonate solution (2 x 100 mL), water (2 x 100 mL), brine (2 x 50 mL), and 
dried over anhydrous MgSO4. The organic portion was concentrated down and 
added to 25% HCl in absolute ethanol (8 mL) at 0 °C with vigorous stirring. The 
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white crystals obtained were filtered and washed with hexanes to afford 
imidazole-1-sulfonyl azide hydrochloride 45 (10.8 g, 70%). 1H NMR (400 MHz, 
D2O):   9.32 (s, 1H), 8.01 (s, 1H), 7.60 (s, 1H). 13C NMR (101 MHz, D2O)   
138.32, 124.73, 120.53. 
General method for the diazo transfer reaction of D-glucosamine
hydrochloride: In a typical experiment, imidazole-1-sulfonyl azide hydrochloride 
45 (2.99 mmol, 1.3 equiv) was added to a suspension of D-glucosamine 
hydrochloride (2.3 mmol, 1 equiv), potassium carbonate (11.59 mmol, 2.4 equiv), 
and copper(II) sulfate pentahydrate (1.2 mmol, 2 mol%)  in methanol (22 mL)   at 
room temperature. The reaction mixture was stirred for at least 10 h and turned 
green. Upon completion of the reaction by TLC, the mixture was concentrated, 
and azeotroped with toluene (3 x 5 mL), then dispersed into distilled pyridine (20 
mL) and acetic anhydride (23 mmol, 10 equiv). Upon completion of the reaction 
(TLC), the mixture was concentrated, extracted with ethyl acetate, washed with 
brine, and purified by silica column chromatography using 10–50% ethyl acetate 
in hexanes to furnish peracetylated azide 46. 
 General method of preparation 49: In a typical experiment, phenyl 
diphenylphosphinite (0.72 mmol, 1.2 equiv) was weighed out in a glove box and 
dissolved in distilled and degassed toluene (2 mL). This was added to an 
anerobic solution of lactol 48 (0.6 mmol, 1 equiv) in toluene (8 mL) at room 
temperature. The reaction mixture was warmed to 60 °C for 2–4 h, then cooled to 
room temperature, concentrated to dryness, and purified by silica gel 
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chromatography using a 50–100% ethyl acetate in hexanes gradient to afford 49 
as a white solid.  
Preparation of D-Glucosamine Trichloroacetimidate Donor 50: To a 
solution of compound 49 (0.24 mmol, 1 equiv) in distilled dichloromethane (4 mL) 
at 0 °C, freshly distilled trichloroacetonitrile (0.72 mmol, 3 equiv), followed by 
freshly distilled DBU (0.12 mmol, 0.5 equiv) were added and stirred at this 
temperature for 6–12 h. The reaction did not reach to completion, but was diluted 
with dichloromethane and passed through a plug of solid ammonium chloride, 
then concentrated and purified by silica gel chromatography using a 50–80% 
ethyl acetate in hexanes gradient with 1% triethylamine to obtain isolated product 
30–60% yield and recovered starting material. 
Preparation of Catalyst precursor Ni(4-FPhCN)4Cl2:  This was prepared by 
following the reported protocol:19 A flame-dried round-bottom flask was charged 
with NiCl2 (87 mg, 0.67 mmol) and  4-fluorobenzonitrile (2.1 g, 16.75 mmol) in 
distilled and degassed CH2Cl2 (2 mL), then stirred at room temperature under an 
argon atmosphere for 30 h. The reaction mixture was then poured into hexanes 
(20 mL) to induce precipitation. After 10 minutes the hexanes layer was 
decanted, and the resulting yellow solid was further washed with hexane (2 × 10 
mL) then transferred into a pre-tared flask and dried under high vacuum 
overnight to afford Ni(4-FPhCN)4Cl2 as a yellowish powder (125 mg, 30%).
General glycosylation with trichloroacetimidate donor using Ni(4-
FPhCN)4(OTf)2: In a typical experiment, Ni(4-FPhCN)4(OTf)2  was generated in
situ from a reaction of Ni(4-FPhCN)4Cl2 (4.81 mg, 0.0078 mmol, 14 mol%), 
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AgOTf (3.82, 0.0148 mmol, 28 mol%), and an activated 4Å molecular sieves (30 
mg) in CH2Cl2 (0.3 mL) cooled to 0 °C, then warmed to room temperature with 
stirring for 1 hour under an  argon atmosphere. The reaction mixture was again 
cooled to 0 °C, then treated with a solution of D-glucosamine trichloroacetimidate 
donor 50 (0.054 mmol, 1 equiv) and acceptor (0.07 mmol, 1.3 equiv) in degassed 
CH2Cl2 (0.3 mL). The reaction mixture was stirred at 0 °C for 1 h, then warmed to 
room temperature for 24 h. The reaction was quenched with triethylamine (15  L, 
0.1 mmol), diluted with dichloromethane (10 mL), then passed through Celite and 
concentrated.  The crude product was purified by silica gel chromatography using 
a 30–50% acetone in hexanes gradient with 1% triethylamine to afford desired 
disaccharide product. 
 Thiotolyl 3,6-di-O-benzyl-4,6-O-p-methoxybenzylidene-2-(4-
(trifluoromethyl)benzylideneamino)- -glucopyranoside (38). Compound 37 
(198 mg, 0.32 mmol) was dried with azeotropic distillation with toluene (3 x 2 
mL), dissolved in distilled and degassed dichloromethane (5 mL), then cooled to 
0 °C under an argon atmosphere. Bu3P (95 L, 0.38 mmol) was added and 
stirred for 1 h at this temperature. When all starting materials were consumed, 
the reaction mixture was treated with 4-trifluoromethylbenzaldehyde (60 L, 0.45 
mmol). After stirring 2 h at 0 °C, the reaction was quenched with cold water (2 
mL), warmed to room temperature, extracted with dichloromethane (3 x 20 mL), 
washed with brine (3 x 5 mL), and dried over sodium sulfate. The crude product 
was purified by silica gel chromatography using a 5–20% ethyl acetate in 
hexanes gradient with 1% triethylamine to afford C2 benzylideneamine 38 as a 
84 
yellowish solid (187 mg, 78% over two steps). 1H NMR (400 MHz, CDCl3):    
8.82 (s, 1H), 8.06 (d, J = 8.0 Hz, 2H), 7.78 (d, J = 8.1 Hz, 2H), 7.27 (m, 10H), 
7.04 (d, J = 7.8 Hz, 4H), 6.83 (m, 4H), 5.22 (d, J = 10.2 Hz, 1H), 4.65 (m, 8H), 
4.47 (m, 2H), 4.16 (t, J = 9.0 Hz, 1H), 3.87 (d, J = 24.2 Hz, 2H), 3.80 (m, 10H), 
2.31 (s, 3H). 
Acetyl 2-azido-3,6-di-O-benzyl-2-deoxy-4,6-p-methoxybenzylidene-
glucopyranoside (40). Compound 37 (212 mg, 0.35 mmol) was dissolved in dry 
acetone (9 mL), and cooled to –30 °C, treated with recrystallized N-
bromosuccinimide (123 mg, 0.69 mmol) dissolved in 1 mL of acetone, then 
warmed  slowly to –20 °C for 1.5 h.  The reaction was quenched at –20 °C with 
saturated sodium bicarbonate (5 mL), then warmed to room temperature, 
extracted with ethyl acetate (3 x 50 mL), washed with brine (3 x 5 mL), dried over 
sodium sulfate, then concentrated and purified by silica gel chromatography 
using a 20–40% ethyl acetate in hexanes gradient  to afford an intermediate 
lactol (175 mg, 90%). 1H NMR (400 MHz, CDCl3):   7.36 (m, 10H), 7.05 (t, J = 
8.7 Hz, 2H), 6.81 (m, 2H), 5.32 (m, 1H), 4.89 (q, J = 6.1 Hz, 1H), 4.72 (dd, J = 
8.3, 10.5 Hz, 1H), 4.56 (m, 3H), 4.44 (dd, J = 5.5, 10.5 Hz, 1H), 4.00 (dd, J = 9.0, 
10.2 Hz, 1H), 3.79 (s, 3H), 3.61 (m, 4H), 3.42 (m, 2H), 3.09 (s, 1H).  
The lactol intermediate (175 mg was subjected to acetylation using acetic 
anhydride (0.1 mL) and pyridine (3 mL), then concentrated to dryness and 
purified by silica gel chromatography to afford glycosyl acetate 40 as a mixture of 
anomers (170 mg, / =1:1, 90%). 1H NMR (400 MHz, CDCl3):    7.50–7.28 (m, 
28H), 7.13–6.95 (m, 5H), 6.87–6.73 (m, 5H), 4.90 (t, J = 3.5 Hz, 2H), 4.86 (d, J = 
85 
3.5 Hz, 2H), 4.77–4.68 (m, 2H), 4.63 (dd, J = 5.3, 11.9 Hz, 3H), 4.53–4.37 (m, 
6H), 3.93 (m, 1H), 3.87 (d, J = 3.2 Hz, 2H), 3.81 (d, J = 7.1 Hz, 2H), 3.80–3.76 
(m, 7H), 3.76–3.68 (m, 6H), 3.67–3.44 (m, 9H), 2.20–2.15 (m, 3H), 2.14 (d, J = 
0.9 Hz, 1H), 2.13–2.11 (m, 3H). 
Acetyl 3,6-di-O-benzyl-2-deoxy-2-p-fluorobenzylideneamino-4,6-p-
methoxybenzylidene glucopyranoside (41). Compound 40 (70 mg, 0.13 mmol) 
dissolved in degassed dichloromethane (2 mL) was treated with tributyl 
phosphine (42  L, 0.17 mmol) at 0 °C for 1 h, followed by addition of p-
fluorobenzaldehyde (40  L, 0.37 mmol) with stirring at 0 °C for 2 h. Aqueous 
workup (cf. 38) afforded benzylideneamine 41 as a yellowish solid and a mixture 
of anomers (/ =1:1, 80 mg, 87% over two steps). 1H NMR (400 MHz, CDCl3):  
 8.83 (s, 1H), 7.94–7.91 (m, 2H), 7.24 (m, 14H), 6.81 (m, 2H), 6.26 (d, J = 3.7 
Hz, 1H), 6.18 (d, J = 11.0 Hz, 1H) 4.63 (m, 6H), 3.98 (m, 8H), 2.13 (s, 3H). 
3,6-Di-O-benzyl-2-deoxy-2-p-fluorobenzylidenamino-4-O-(4,6-p-methoxy- 
benzylidene)--glucopyranosyl trichloroacetimidate (42). Glycosyl acetate 41 
( 38 mg, 0.06 mmol) was dissolved in THF (0.3 mL) and treated with 7 M 
ammonia in methanol (0.3 mL) at –40 °C, then warmed to 0 °C for 2 h. The crude 
reaction mixture (30 mg, 0.05 mmol) was concentrated to dryness, redissolved in 
distilled dichloromethane (0.8 mL), treated with trichloroacetonitrile (15  L, 0.15 
mmol) and DBU (4  L, 0.026 mmol), and stirred at 0 °C for 2 h. The reaction 
mixture was concentrated and purified by silica gel chromatography using a 10–
30% ethyl acetate in hexanes gradient with 1% triethylamine to afford -
trichloroacetimidate 42 as an oil (24 mg, 54% over two steps). 1H NMR (500 
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MHz, C6D6):    8.57 (s, 1H), 8.09 (s, 1H), 7.43 (m, 2H), 7.34 (m, 2H), 7.19 (m, 
6H), 7.01 (m, 2H), 7.03 (m, 2H), 6.78 (dd, J = 2.1, 8.7 Hz, 2H), 6.69 (m, 2H), 6.40 
(d, J = 8.2 Hz, 1H), 4.86 (d, J = 10.9 Hz, 1H), 4.77 (m, 2H), 4.68 (d, J = 10.9 Hz, 
1H), 4.61 (d, J = 11.3 Hz, 1H), 4.56 (d, J = 11.6 Hz, 1H), 4.51 (m, 2H), 4.39 (m, 
2H), 4.05 (t, J = 9.2 Hz, 1H), 4.02 (t, J = 9.1 Hz, 1H), 3.74 (m, 5H), 3.31 (s, 4H), 
3.29 (m, 2H). 13C NMR (126 MHz, C6D6):   163.19, 160.88, 159.43, 138.67, 
138.60, 132.41, 130.85, 130.25, 130.18, 129.60, 129.31, 128.29, 128.23, 128.20, 
128.05, 127.98, 127.88, 127.68, 127.59, 127.49, 127.30, 115.52, 115.35, 113.70, 
97.54, 91.17, 83.48, 80.58, 77.02, 76.50, 75.94, 74.72, 74.53, 74.31, 73.97, 
73.22, 68.44, 54.41, 36.47, 24.66, 23.18. 
1,3,4,6-tetra-O-acetyl-2-azido-2-deoxyglucopyranoside (46). Glucosamine 
hydrochloride (0.2 g, 0.93 mmol) was treated with diazo transfer reagent 45 (0.23 
g, 1.12 mmol), potassium carbonate (0.335 g, 2.42 mmol), and copper sulfate 
pentahydrate (50 mg, 0.2 mmol) in methanol (5.5 mL) with stirring at room 
temperature for 12 h. Upon completion for the reaction by TLC, the mixture was 
concentrated to dryness, and azeotroped with toluene (3 x 5 mL), then dispersed 
into pyridine (5 mL) and treated with acetic anhydride (1 mL) with stirring at room 
temperature for 18 h. The reaction mixture was then concentrated and purified by 
silica gel chromatography using a 10–50% ethyl acetate in hexanes gradient to 
afford azidoglucose tetraacetate 46 as white solid (: = 2:3, 291 mg, 84%). 1H 
NMR (400 MHz, CDCl3):   6.38 (d, J = 3.7 Hz, 1H), 5.65 (d, J = 8.6 Hz, 1H), 5.54 
(dd, J = 9.4, 10.5 Hz, 1H), 5.18 (m, 3H), 4.38 (m, 3H), 4.1Hz, 3H), 3.89 (ddd, J = 
87 
2.2, 4.5,  9.8 Hz, 1H), 3.75 (ddd, J = 2.1, 5.8, 9.9 Hz, 2H), 2.27 (s, 6H), 2.18 (s, 
3H), 2.17 (s, 3H), 2.15 (s, 5H), 2.12 (s, 2H), 2.10 (s, 3H). 
S-Benzoxazolyl 3,4,6-tri-O-acetyl-2-azido-2-deoxy-1-thio-
glucopyranoside (47). Glycosyl acetate 46 (1.2 g, 3.22 mmol) was dried by 
azeotropic distillation with toluene (3 x 2 mL), then treated with a solution of 2-
mecaptobenzoxazole (1.1 g, 7.28 mmol) and activated 4Å molecular sieves (1.5 
g) dispersed in dry dichloromethane (30 mL). The reaction mixture was cooled to 
0 °C was and treated with BF3.Et2O (2 mL, 15.8 mmol), then warmed to room 
temperature and stirred for 48 h. The reaction was quenched with aqueous 
sodium bicarbonate solution at 0 °C, then extracted with dichloromethane (3 x 
100 mL), washed with brine (3 x 10 mL), dried over sodium sulfate, concentrated 
and purified by silica gel chromatography using a 10–50% ethyl acetate in 
hexanes gradient to afford S-benzoxazolyl glycoside 47 as a syrup (920 mg,  :  
= 1:1, 62%). Selected major peaks of 1H NMR (400 MHz, CDCl3):  7.65–7.60 
(m), 7.46 (d, J = 8.7 Hz), 7.29 (m), 6.27 (d, J = 3.6 Hz), 5.54 (d, J = 8.3 Hz), 5.42 
(m), 5.13–4.98 (m), 4.31–4.18 (m), 4.12–3.99 (m) 3.99–3.85 (m), 3.79 (m), 3.69–
3.60 (m), 2.17 (s), 2.08 (s), 2.07 (s), 2.06 (s), 2.05 (s), 2.02 (s), 2.00 (s). 
3,4,6-Tri-O-acetyl-2-azido-2-deoxy-D-glucopyranose (48). Glycosyl acetate 
46 (338 mg, 0.9 mmol) was dissolved in THF (2 mL) and treated dropwise with 7 
M ammonia solution in methanol (2 mL) at –40 °C using a cannula, then warmed 
to 0 °C and stirred for 2 h. The reaction mixture was concentrated and purified by 
silica gel chromatography using a 10–50% ethyl acetate in hexanes gradient to 
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afford compound 50 as white solid (232 mg, 78%).  1H NMR (400 MHz, CDCl3):  
  5.51 (t, J = 10.5 Hz, 1H), 5.37 (s, 1H), 5.12–4.89 (m, 2H), 4.71 (d, J = 8.0 Hz, 
1H), 4.30–4.16  (m, 4H), 4.15–4.02 (m, 4H), 3.69 (m, 1H), 3.39 (dd, J = 3.4, 10.5 
Hz, 1H), 2.06 (s, 9H), 2.02 (s, 6H), 1.99 (s, 3H). IR: 3430, 2931, 2113, 1753, 
1236 cm-1. 
3,4,6-Tri-O-acetyl-2-deoxy-2-diphenylphosphinamido-D-glucopyranose 
(49). Azidoglucose 48 (115 mg, 0.35 mmol) was treated with commercially 
available phenyl diphenylphosphinite (115 mg, 0.41 mmol) as described 
previously (see General Methods) to afford 50 as a white solid (115 mg, 68%).  
1H NMR (400 MHz, CDCl3):    7.77 (m, 4H), 7.42 (m, 6H), 5.39 (s, 1H), 5.33 (t, J 
= 9.8 Hz, 1H), 4.86 (t, J = 9.8 Hz, 1H), 4.25 (m, 2H), 4.04 (m, 2H), 3.07 (m, 1H), 
2.12 (s, 3H), 2.04 (s, 3H), 1.96 (s, 3H). 13C NMR (101 MHz, CDCl3):   170.77, 
169.58, 132.58, 132.48, 132.26, 132.11, 131.60, 131.51, 130.74, 129.42, 128.70, 
128.59, 128.47, 92.94, 72.11, 68.62, 66.53, 62.02, 55.06, 20.97, 20.69, 20.58.  
31 P NMR (162 MHz, CDCl3):   26.17. 
 3,4,6-Tri-O-acetyl-2-deoxy-2-diphenylphosphinamido--glucopyranosyl 
trichloroacetimidate (50). Compound 49 (200 mg, 0.4 mmol) was treated with 
CCl3CN (125 L, 1.25 mmol) and DBU (30 L, 0.2 mmol) in dry dichloromethane 
(6 mL) at 0 °C for 12 h.  The reaction mixture was passed through an ammonium 
chloride plug, concentrated, then purified by silica gel chromatography using a 
50–90% ethyl acetate in hexanes gradient with 1% triethylamine to afford 
trichloroacetimidate 50 as a white crystalline solid (160 mg, 60%). 1H NMR (500 
MHz, CDCl3):   8.88 (s, 1H), 7.80–7.76 (m, 4H), 7.52 (m, 2H), 7.44 (ddt, J = 8.6, 
89 
10.8, 5.3 Hz, 4H), 6.44 (d, J = 3.7 Hz, 1H), 5.36 (t, J = 10.0 Hz, 1H), 5.11 (t, J = 
9.9 Hz, 1H), 4.24 (dd, J = 4.1, 12.5 Hz, 1H), 4.10 (ddd, J = 2.3, 4.2, 10.3 Hz, 1H), 
4.05 (dd, J = 2.3, 12.4 Hz, 1H), 3.56 (ddt, J = 9.9, 11.5, 3.7 Hz, 1H), 3.23 (dd, J = 
7.0, 11.5 Hz, 1H), 2.16 (s, 3H), 2.03 (s, 6H). 13C NMR (126 MHz, CDCl3):   
171.76, 170.71, 169.41, 160.70, 132.52, 132.36, 132.30, 132.23, 132.00, 131.92, 
129.03, 128.93, 128.82, 128.72, 109.83, 96.51, 90.98, 71.68, 70.29, 67.59, 
61.55, 53.86, 21.31, 20.80, 20.74. 31P NMR (203 MHz, CDCl3):    22.88. IR: 
3317, 3276, 3185, 2958, 1749, 1677, 1438, 1369, 1224, 1041, 732 cm-1. []D25  = 
+325° (c 0.02, CH2Cl2). 
 Isopropyl 3,4,6-tri-O-acetyl-2-deoxy-2-diphenylphosphinamido--D-
glucopyranoside (55). Trichloroacetimidate donor 50 (18 mg, 0.027 mmol) was 
dried by azeotropic distillation with toluene (3 x 1 mL), then treated with freshly 
distilled isopropanol (4 L, 0.079 mmol) and Ni(4-FPhCN)4(OTf)2 catalyst (17.5 
mol%) prepared in situ from AgOTf (2.5 mg, 0.0097 mmol, 35 mol%) and Ni(4-
FPhCN)4Cl2 (3 mg, 0.0048 mmol, 17.5 mol%) in dichloromethane (0.25 mL).  The 
reaction mixture was stirred at 0 °C for 12 h, at rt for an additional 12 h, then 
quenched with triethylamine (10 L). This was concentrated and purified by 
preparative TLC using 45% acetone in hexanes gradient with 1% triethylamine to 
afford isopropyl glycoside 55 as a white solid (4 mg, 26%). 1H NMR (500 MHz, 
CDCl3):    7.96 (dd, J = 7.6, 11.8 Hz, 2H), 7.88 (dd, J = 7.7, 11.9 Hz, 2H), 7.45 
(m, 6H), 5.07 (t, J = 9.7 Hz, 1H), 4.88 (t, J = 9.6 Hz, 1H), 4.49 (d, J = 8.0 Hz, 1H), 
4.22 (dd, J = 5.4, 12.2 Hz, 1H), 4.06  (m, 2H), 3.64 (ddd, J = 2.5, 5.3, 9.9 Hz, 
1H), 3.15 (sept., J = 8.04 Hz, 1H), 2.82 (dd, J = 4.7, 10.6 Hz, 1H), 2.65 (d, J = 7.4 
90 
Hz, 1H), 2.18 (s, 3H), 2.04 (s, 3H), 1.99 (s, 3H), 1.31 (m, 6H). 13C NMR (126 
MHz, CDCl3)   171.66, 170.67, 169.48, 134.05, 133.22, 133.14, 132.07, 131.99, 
131.90, 131.85, 131.23, 128.48, 128.44, 128.38, 128.34, 101.18, 74.26, 74.16, 
72.14, 71.75, 68.82, 62.38, 56.78, 46.34, 23.45, 21.82, 21.31, 20.76, 20.65. 31P 
NMR (203 MHz, CDCl3) :   21.99. 
3,4,6-Tri-O-acetyl-2-deoxy-2-diphenylphosphinamido--glucopyranosyl-
(13)-4,6-O-benzylidene-D-glucal (56). Trichloroacetimidate donor 50 (25 mg, 
0.038 mmol) was treated with glycosyl acceptor  51 (11 mg, 0.047 mmol) and 
Ni(4-FPhCN)4(OTf)2 catalyst (16 mol%) prepared in situ from AgOTf (3.3 mg, 
0.0128 mmol, 32 mol%) and Ni(4-FPhCN)4Cl2 (3.9 mg, 0.0063  mmol, 16 mol %) 
in dichloromethane (1 mL) at 0 °C, following the procedure described above (cf. 
55). The crude product was purified by preparative TLC using 45% acetone in 
hexanes with 1% triethylamine to afford disaccharide 56 as a white solid (3 mg, 
11%). 1H NMR (800 MHz, CDCl3):   7.88 (dd, J = 7.6, 11.7 Hz, 2H), 7.81 (dd, J = 
7.6, 11.6 Hz, 2H), 7.49 (t, J = 7.6 Hz, 2H), 7.43 (m, 4H), 7.37 (m, 4H), 6.44 (d, J 
= 3.1 Hz, 1H), 5.58 (s, 1H), 5.04 (t, J = 9.7 Hz, 1H), 5.00 (dd, J = 2.1, 6.2 Hz, 
1H), 4.92 (t, J = 9.6 Hz, 1H), 4.70 (dd, J = 4.4, 7.6 Hz, 2H), 4.37 (dd, J = 5.0, 10.5 
Hz, 1H), 2.13 (s, 3H), 1.97 (s, 3H), 1.96 (s, 3H). 13C NMR (126 MHz, CDCl3):   
171.52, 170.74, 169.54, 145.25, 137.18, 133.30, 132.79, 132.08, 131.35, 129.49, 
128.57, 126.16, 101.99, 101.68, 101.33, 78.94, 74.72, 74.32, 71.72, 68.77, 





midate donor 50 (20 mg, 0.031 mmol) was treated with glycosyl acceptor 52 (18 
mg, 0.038 mmol) and Ni(4-FPhCN)4(OTf)2 catalyst (14 mol%) prepared in situ 
from AgOTf (2.36 mg, 0.009 mmol, 28 mol%) and Ni(4-FPhCN)4Cl2 (2.81 mg, 
0.0045  mmol, 14 mol%) in dichloromethane (0.5 mL) along with 4Å molecular 
sieves (20 mg), as described above (cf. 55). The reaction mixture was stirred for 
26 hours at rt followed by workup and purification by preparative TLC using 45% 
acetone in hexanes with 1% triethylamine to afford disaccharide 57 as a white 
solid (8 mg, 27%). 1H NMR (500 MHz, CDCl3):   7.97 (dd, J = 8.0, 12 Hz, 2H), 
7.85–7.79 (m, 2H), 7.82, 7.31 (m, 19H), 7.05 (m, 2H), 5.06 (d, J = 10.4 Hz, 1H), 
4.84 (m, 5H), 4.61 (m, 3H), 4.15 (dd, J = 4.7, 12.3 Hz, 1H), 4.08 (m, 2H), 4.02 
(dd, J = 2.5, 12.3 Hz, 1H), 3.81 (dt, J = 10.2, 3.1 Hz, 1H), 3.71 (d, J = 8.0 Hz, 
1H), 3.60 (m, 1H), 3.54 (dq, J = 9.8, 3.7 Hz, 2H), 3.47 (ddd, J = 2.5, 4.8, 9.9 Hz, 
1H), 3.34 (s, 3H), 3.09 (quint., J = 9.6 Hz, 1H), 2.17 (s, 3H), 1.98 (d, J = 1.5 Hz, 
6H). 13C NMR (126 MHz, CDCl3):  171.80, 170.77, 169.50, 138.63, 138.01, 
133.56, 132.14, 131.91, 130.68, 129.64, 128.76, 128.63, 128.59, 128.39, 128.19, 
127.99, 102.81, 98.45, 82.29, 80.09, 76.65, 76.13, 74.24, 73.89, 73.55, 72.04, 
69.74, 68.70, 67.75, 62.15, 56.54, 55.67, 21.55, 20.84, 20.77. 31P NMR (203 





imidate donor 50 (35 mg, 0.054 mmol) was treated with acceptor 53 (45 mg, 
0.096 mmol) and Ni(4-FPhCN)4(OTf)2 (14.5 mol%) prepared in situ from AgOTf 
(3.3 mg, 0.0148 mmol, 27 mol%) and Ni(4-FPhCN)4Cl2 (4.81 mg, 0.0078  mmol, 
14.5 mol%) in dichloromethane (0.55 mL) along with 4Å molecular sieves (30 
mg), as described above (cf. 55). The reaction mixture was stirred for 48 h at 
room temperature followed by workup and purification by preparative TLC using 
45% acetone in hexanes with 1% triethylamine to afford 58 as white solid (8 mg, 
16%). 1H NMR (500 MHz, CDCl3):  8.02 (dd, J = 4.05, 7.5 Hz, 2H), 7.86 (dd, J = 
7.2, 11.3 Hz, 2H), 7.49 (m, 4H), 7.31 (m, 15H), 7.13 (m, 2H), 5.00 (d, J = 10.5 
Hz, 1H), 4.86 (m, 5H), 4.69 (d, J = 10.8 Hz, 1H), 4.59 (d, J = 11.4 Hz, 1H), 4.32 
(d, J = 7.2 Hz, 1H), 4.21–4.15 (m, 2H), 4.03 (dd, J = 4.8, 10.0 Hz, 2H), 3.72 (t, J 
= 8.9 Hz, 1H), 3.66–3.45 (m, 5H), 3.44–3.39 (m, 4H), 3.11 (quint., J = 9.4 Hz, 
1H), 2.19 (s, 3H), 2.0 (s, 3H), 1.97 (s, 3H). 13C NMR (126 MHz, CDCl3):  171.86, 
170.80, 169.56, 138.49, 138.42, 138.31, 133.72, 133.64, 132.22, 132.09, 132.01, 
128.76, 128.72, 128.57, 128.54, 128.45, 128.35, 128.26, 127.95, 127.87, 105.07, 
103.14, 103.06, 84.95, 82.35, 77.41, 76.02, 74.91, 74.67, 74.61, 74.04, 72.01, 
68.66, 68.14, 62.19, 57.67, 56.69, 21.54, 20.87, 20.77. 
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